Page last updated: 2024-08-16

resveratrol and Breast Neoplasms

resveratrol has been researched along with Breast Neoplasms in 273 studies

Research

Studies (273)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (2.93)	18.2507
2000's	81 (29.67)	29.6817
2010's	144 (52.75)	24.3611
2020's	40 (14.65)	2.80

Authors

Authors	Studies
De-Eknamkul, W; Miyase, T; Monthakantirat, O; Noguchi, H; Umehara, K; Warashina, T; Yoshinaga, Y	1
Bagnacani, A; Bertini, S; Carboni, I; Ghidoni, R; Macchia, M; Minutolo, F; Placanica, G; Prota, G; Rapposelli, S; Sacchi, N; Sala, G	1
Kuo, ML; Su, JL; Yang, CY; Yen, ML; Zhao, M	1
Armstrong, MD; Arteaga, CL; Brown, HA; Buck, JR; Cho, HP; Criswell, TL; Lindsley, CW; Scott, SA; Selvy, PE; Thomas, AL	1
Bertini, S; Calderone, V; Carboni, I; Ghidoni, R; Macchia, M; Maffei, R; Martelli, A; Martinelli, A; Minutolo, F; Rajabi, M; Testai, L; Tuccinardi, T	1
Aphale, S; Bhat, HK; Chatterjee, A; Dandawate, P; Jagyasi, A; Moghe, A; Padhye, S; Ronghe, A; Rub, R; Siddiqui, A; Singh, B; Venkateswara Swamy, K	1
Bertamino, A; Campiglia, P; Caruso, A; Chimento, A; Gomez-Monterrey, IM; Milite, C; Musella, S; Novellino, E; Pezzi, V; Sala, M; Saturnino, C; Sinicropi, MS; Sirianni, R; Tortorella, P	1
Dong, C; Hu, Z; Huang, J; Ning, W; Tang, C; Yang, L; Zhang, S; Zhou, HB	1
Ammazzalorso, A; Amoroso, R; Cataldi, A; De Filippis, B; Della Valle, A; Fantacuzzi, M; Gallorini, M; Gambacorta, N; Giampietro, L; Maccallini, C; Mollica, A; Nicolotti, O	1
Bartosz, G; Gajewska, A; Hikisz, P; Komorowska, D; Rodacka, A	1
Costa, PSD; El-Bacha, T; Ferreira, C; Fialho, E; Ramos, PS; Silva, JL	1
Jevtić, VV; Matić, MM; Obradović, AD; Ognjanović, BI; Paunović, MG; Stojković, DL	1
Li, W; Li, Z; Wang, Z; Yu, H; Zhai, Y; Zhang, D; Zhang, J; Zhou, Y	1
Chen, J; Cheuk, IW; Ho, JC; Kwong, A; Lam, SS; Shin, VY; Siu, M	1
Bian, Y; Li, G; Qiao, M; Ren, G; Wang, X; Zheng, Z; Zhu, H	1
Cattivelli, A; Cortés-Martín, A; Dávalos, A; Del Pozo-Acebo, L; Del Saz, A; Espín, JC; González-Sarrías, A; Iglesias-Aguirre, CE; López de Las Hazas, MC; Vallejo, F	1
Pai Bellare, G; Sankar Patro, B	1
Dewangan, HK; Shah, K; Singh, S	1
Gao, HF; Li, H; Li, TT; Liu, J; Lu, MD; Nie, JH; Wang, K; Wu, ML; Ye, HS	1
Gadag, S; Garg, S; Hari, G; Narayan, R; Nayak, UY; Nayak, Y; Pai, KSR; Sabhahit, JN	1
Chatterjee, S; Das, B; Das, C; Dash, SR; Kundu, CN; Paul, S; Sinha, S	1
Ene, AG; Ficai, A; Ficai, D; Vladu, AF	1
Li, D; Song, C; Zhang, J; Zhao, X	1
Behroozaghdam, M; Bishayee, A; De Greef, D; Dehghani, M; Hasani Sadi, F; Hashemi, M; Javanshir, S; Kamali, D; Mirzaei, S; Rashidi, M; Tabari, T; Zabolian, A; Zarepour, A; Zarrabi, A	1
Li, L; Li, SQ; Ma, JF; Yin, Z; Zhang, NX	1
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X	1
Akbarizadeh, AR; Fatehi, R; Firouzabadi, N; Rashedinia, M; Zamani, M	1
Acconcia, F; Battocchio, C; Ciccone, L; Cracco, P; Fiocchetti, M; Iucci, G; Marino, M; Montalesi, E; Moreno, S; Muzzi, M; Nencetti, S; Orlandini, E; Venditti, I	1
ALkharashi, NA	1
Aghaz, F; Khazaei, M; Raygani, AV; Sajadimajd, S	1
Chen, X; He, H; Jiang, W; Li, Y; Sun, M; Tian, W; Yu, J; Zhang, S	1
Chorilli, M; Di Filippo, LD; Dos Reis, LR; Duarte, JL; Luiz, MT; Marena, GD; Oliveira Silva, VA; Sábio, RM; Sousa Araújo, VH; Souza Fernandes, L	1
Das, S; Matthews, J; Somisetty, VS; Ulven, SM	1
Bloebaum, P; Jurisson, SS; Katti, KK; Katti, KV; Khoobchandani, M; Panjtan Amiri, K; Raphael Karikachery, A; Thipe, VC	1
Avelino-Cruz, JE; Felix, R; Flores, A; González-González, L; González-Ramírez, R; Monjaraz, E	1
Baer-Dubowska, W; Cykowiak, M; Licznerska, B; Szaefer, H	1
Atella, GC; de Andrade, IR; Ferreira, C; Fialho, E; Gomes, L; Mermelstein, CS; Passos, CLA; Silva, JL; Sorgine, M	1
Chen, K; Chen, L; Han, X; Sun, L; Wu, H; Zhu, F	1
Ahmad, Z; Ahmed, F; Farooq, N; Husnain, T; Ijaz, B; Sarwar, MB	1
Büsselberg, D; Kubatka, P; Liskova, A; Mathews Samuel, S; Varghese, E	1
Anwar, H; Badgeley, A; Lakshmikuttyamma, A; Lawrence, K; Murphy, P; Selvakumar, P; Sharma, U	1
Hu, C; Jiao, K; Li, Y; Li, Z; Teng, M; Wu, M; Yang, K; Zhen, J; Zhou, M; Zhou, Q	1
Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I	1
Chen, HF; Chen, LM; Gu, JY; Yang, MF; Yang, ZH; Yao, X; Zheng, X; Zheng, ZT	1
Amini, P; Aryafar, T; Ashrafizadeh, M; Eftekhari, SM; Farhood, B; Khalafi, L; Mahdavi, SR; Musa, AE; Najafi, M; Nodooshan, SJ	1
Alves Passos, CL; Ferreira, C; Fialho, E; Schmidt, B; Silva, JL	1
Cheng, R; Dong, J; Han, J; Li, L; Yang, W	1
Ceramella, J; Cirillo, F; Iacopetta, D; Lappano, R; Longo, P; Maggiolini, M; Mariconda, A; Martinelli, F; Puoci, F; Rosano, C; Saturnino, C; Sinicropi, MS; Talia, M	1
Filippi-Chiela, E; Lenz, G; Puga, R; Trindade, C; Vargas, JE	1
Anayiotos, A; Andreou, C; Constantinou, AI; Dietis, N; Gregoriou, G; Gregoriou, Y; Kapnisis, K; Prokopi, M; Strati, K; Yilmaz, V	1
Asakura, T; Furuta, H; Hakuno, F; Iida, K; Ishikawa, T; Katayama, Y; Lu, P; Lu, Y; Nagata, K; Okamoto, K; Shimada, N; Shimizu, K; Sui, M; Suzuki, M; Takahashi, SI; Tatsuzaki, J; Terada, T; Yang, J; Zhang, M	1
Choi, HJ; Fukui, M; Wang, P; Zhu, BT	1
Avena, P; Bonomo, MG; Ceramella, J; Chimento, A; De Luca, A; Iacopetta, D; Infantino, V; Parisi, OI; Pezzi, V; Santarsiero, A; Saturnino, C; Sinicropi, MS	1
Andò, S; Augimeri, G; Barone, I; Bonofiglio, D; Catalano, S; De Amicis, F; Giordano, C; Lanzino, M; Montalto, FI	1
Alamolhodaei, NS; Hayes, AW; Karimi, G; Ramezani, M; Tsatsakis, AM	1
Bourgine, G; Efstathiou, T; Lecomte, S; Lelong, M; Pakdel, F; Saligaut, C	1
Azad, N; Iyer, AKV; Kaushik, V; Venkatadri, R	1
Gurer-Orhan, H; Ince, E; Konyar, D; Saso, L; Suzen, S	1
Dewangan, J; Rath, SK; Srivastava, S; Tandon, D; Verma, AK; Yapuri, A	1
Barbisan, LF; da Silva, FRM; da Silveira, LTR; de Lima E Silva, TC; Diniz, OHG; Fragoso, MF; Martinez, MF; Scarano, WR; Zapaterini, JR	1
Beaudoin, MS; Connor, MK; Sauvé, OS; Theriau, CF; Wright, DC	1
Bhat, HK; Bhat, NK; Chatterjee, A; Padhye, SB; Ronghe, A; Spade, DA	1
Bao, X; Chen, C; Chen, S; Chen, T; Guo, W; Li, Y; Ren, B; Tang, B; Wang, D; Wang, H; Wang, W; Wang, Y; Yang, Q; Zhang, L	1
Abu-Serie, MM; El-Lakany, SA; Elgindy, NA; Elzoghby, AO; Helmy, MW	1
Bowers, LW; Cui, Z; DiGiovanni, J; Doerstling, SS; Ford, NA; Glickman, RD; Hursting, SD; Khatib, SA; Niu, M; Pruski, M; Rossi, EL; Yang, P	1
Li, M; Li, S; Wen, X; Zhang, L; Zhao, H	1
Goormaghtigh, E; Mignolet, A; Wood, BR	1
Azzolin, VF; Barbisan, F; Bauermann, LF; Baumhardt, T; Bordin, FPR; Cadoná, FC; da Costa Araldi, IC; da Cruz, IBM; Duarte, MMMF; Teixeira, CF	1
Bekhit, AA; El-Far, SW; Elzoghby, AO; Helmy, MW; Hussein, AA; Khattab, SN	2
Kim, DH; Suh, J; Surh, YJ	1
Caixeta, ES; Coelho, LF; de Freitas Silva, M; Ferreira-Silva, GÁ; Graravelli, GY; Guirelli, IM; Horvath, RO; Ionta, M; Pereira, RM; Viegas, C	1
Albino-Sanchez, ME; Bermudez-Cruz, R; Diaz-Chavez, J; García-Carrancá, A; Garcia-Mena, J; Garcia-Villa, E; Gariglio, P; Herrera, LA; Leon-Galicia, I	1
Bai, JY; Chen, JM; Yang, KX	1
Khazaei, M; Khazaei, MR; Mirzapur, P; Moradi, MT	1
Chen, C; Du, L; Guo, M; Wang, J; Wang, X; Yin, D; Yin, J; Yin, X; Zhang, B; Zhang, L; Zhao, F; Zhao, Y; Zhou, X	1
Ávila-Gálvez, MÁ; Espín, JC; González-Sarrías, A	1
Abedi, SM; Behzadi, R; Ghasmi, M; Hallajian, F; Hayati, E; Karimi, H; Rezazadeh, F; Sadeghzadeh, N	1
Gao, Y; Tollefsbol, TO	1
Bagde, A; Chowdhury, N; Kutlehria, S; Patel, K; Singh, M; Vhora, I	1
Ascenzi, P; Cipolletti, M; Fiocchetti, M; Marino, M; Montalesi, E; Nuzzo, MT	1
Chen, X; Xiao, C; Yang, H	1
Ding, F; Jin, X; Liu, Y; Lu, X; Wang, J; Wei, Y; Yang, S	1
Liu, T; Wang, X; Yao, Y; Zhang, D	1
Casaburi, I; Chimento, A; De Amicis, F; Montalto, FI; Pezzi, V; Sirianni, R	1
Jäger, W; Maier-Salamon, A; Poschner, S; Thalhammer, T	1
Chen, QL; Lu, YY; Su, SB; Sun, Y; Zhang, H; Zhao, M; Zhou, QM	1
Hu, C; Jiao, K; Li, Z; Liu, Y; Teng, M; Wu, M; Zhen, J	1
Cho, KH; Jeong, BY; Lee, HY; Park, CG	1
Aghamiri, S; Aghemiri, M; Jafarpour, A; Shoja, M; Zandsalimi, F	1
Chen, FP; Chien, MH	3
Chen, Y; Jiang, H; Ren, F; Zhang, W	1
Beg, S; Kaur Narang, J; Lather, V; Pandita, D; Poonia, N; Sharma, T; Singh, B	1
Benítez, R; Iturri, J; Leporatti, S; Moreno-Cencerrado, A; Toca-Herrera, JL; Vivanco, MD; Weber, A	1
Chang, MC; Chang, YC; Chen, CC; Chen, KY	1
Beetch, M; Flanagan, JM; Flower, K; Harandi-Zadeh, S; Lubecka, K; Shen, K; Stefanska, B; Suderman, M	1
Da Silva, D; Gomez, LS; Marcondes, MC; Meyer-Fernandes, JR; Ramos-Santos, L; Sola-Penna, M; Zancan, P	1
Brighenti, F; Calani, L; Crozier, A; Del Rio, D; Fietta, E; Maggi, A; Meda, C; Ottonello, S; Ruotolo, R	1
Beldiman, C; El'skaya, A; Gralievska, N; Groisman, I; Harel-Bellan, A; Kratassiouk, G; Negrutskii, B; Pinna, G; Porto, E; Vislovukh, A	1
Arechaga-Ocampo, E; Díaz-Chávez, J; Domínguez-Gómez, G; Flores-Pérez, A; Fonseca-Sánchez, MA; Fuentes-Mera, L; Gariglio, P; López-Camarillo, C; Marchat, LA; Mendoza-Hernández, G; Palacios-Rodríguez, Y	1
Bennington, JL; Dairkee, SH; Luciani-Torres, G; Meng, Z; Moore, DH; Sayeed, A	1
Heo, YS; Hwang, MK; Lee, HJ; Lee, KW; Song, NR	1
Feng, J; Li, Y; Ma, HZ; Miao, S; Shi, XP; Wen, AD; Wu, Y; Xin, HL; Zhang, W; Zhang, XF	1
Chen, WJ; Hong, HM; Hsu, LS; Lin, CL; Pan, MH; Tsai, JH; Way, TD	1
Barrajón-Catalán, E; Catania, A; Cicirata, F; Micol, V; Nicolosi, S	1
Chung, MY; Jang, TS; Kang, NJ; Lee, HJ; Lee, KW; Seo, SG; Song, NR	1
Harada, N; Inui, H; Isayama, A; Ito, Y; Mitani, T; Nakano, Y; Takenaka, S; Tanimori, S; Yamaji, R	1
Bertamino, A; Campana, C; Campiglia, P; Caruso, A; Chimento, A; Gomez-Monterrey, IM; Martire, E; Musella, S; Novellino, E; Parisi, OI; Pezzi, V; Puoci, F; Sala, M; Saturnino, C; Sinicropi, MS; Sirianni, R	1
Borg, JL; Papoutsis, AJ; Romagnolo, DF; Selmin, OI	2
Choi, WS; Chung, HY; Jung, JH; Kim, HS; Kim, TH; Lee, BM; Shin, YJ; Won, AJ	1
Clarke, K; Qin, W; Sauter, ER; Weiland, T; Zhang, K	1
Choudhuri, T; Das, D; Kundu, CN; Mohapatra, P; Satapathy, SR; Siddharth, S	1
Cai, JY; Liang, ZH; Yang, F; Yang, PH; Zhang, L	1
Chottanapund, S; Hunsonti, P; Navasumrit, P; Ruchirawat, M; Timtavorn, S; Van den Berg, M; Van Duursen, MB	1
Ashida, H; Harada, N; Inui, H; Ito, Y; Mitani, T; Nakano, Y; Yamaji, R	1
Böhmdorfer, M; Brenner, S; Giessrigl, B; Jäger, W; Pignitter, M; Riha, J; Schueller, K; Somoza, V; Stieger, B; Szekeres, T; Thalhammer, T	1
Bai, Q; Chang, H; Fu, Y; Mi, M; Peng, X; Yi, L; Zhou, Y; Zhu, J	1
Bojková, B; Ekmekcioglu, C; Fedoročko, P; Jäger, W; Jendželovský, R; Kajo, K; Kassayová, M; Kisková, T; Kokošová, N; Kubatka, P; Maier-Salamon, A; Mikeš, J; Orendáš, P; Papčová, Z; Rentsen, E; Svoboda, M; Thalhammer, T	1
Herbert, BS; Sprouse, AA	1
Alayev, A; Berger, SM; Holz, MK; Kramer, MY; Schwartz, NS	1
Chen, M; Chen, R; Morott, J; Repka, MA; Wang, S; Wang, Y	1
Cheng, GY; Chin, YT; Davis, PJ; Fu, E; Hsieh, MT; HuangFu, WC; Lee, YS; Lin, HY; Liu, LF; London, D; Tang, HY; Tsai, PW; Wang, CC; Wang, SH; Yang, SH; Yen, Y	1
Aldebasi, YH; Aljarbou, AN; Faisal, SM; Khan, A; Khan, MA	1
Ho, HO; Hsieh, CM; Jhan, HJ; Sheu, MT; Wang, CJ	1
Abdalla, MOA; Fujiwara, S; Iwase, H; Maehara, K; Matsumori, H; Nakao, M; Ohkawa, Y; Saitoh, N; Tomita, S	1
Abdel-Latif, GA; Abdel-Naim, AB; Al-Abbasi, FA; Al-Abd, AM; Khalifa, AE; Tadros, MG	1
Das, D; Kundu, CN; Mohapatra, P; Nayak, A; Satapathy, SR; Siddharth, S	1
Chang, TC; Changou, CA; Chin, YT; Davis, PJ; Fu, E; HuangFu, WC; Lai, HY; Lin, HY; Liu, LF; Yang, SH	1
Chang, SS; Chou, CK; Ding, Q; Hortobagyi, GN; Hsu, JL; Hsu, JM; Hsu, YH; Hung, MC; Huo, L; Kim, J; Ko, HW; LaBaff, AM; Lai, CC; Lai, YJ; Lee, DF; Li, CW; Li, LY; Lim, SO; Sun, HL; Tsai, CH; Tsai, FJ; Wang, H; Wang, Y; Wu, Y; Xia, W; Yamaguchi, H	1
Bishayee, A; Biswas, J; Sarkar, N; Sinha, D	1
Azad, N; Iyer, AK; Muni, T; Venkatadri, R; Yakisich, JS	1
Guan, X; Gustafsson, JÅ; Luo, J; Strom, A; Wang, Y; Yang, F; Yin, Y; Zhang, W	1
Guo, F; Liang, W; Meng, J; Wang, C; Xu, H; Yang, XD	1
Abdalla, F; Bhat, HK; Bhat, NK; Chatterjee, A; Dandawate, P; Padhye, S; Ronghe, A; Singh, B	1
Caruso, A; Chimento, A; Pezzi, V; Saturnino, C; Sinicropi, MS; Sirianni, R	1
Arechaga Ocampo, E; García Mena, J; Gariglio, P; López-Camarillo, C; Marchat, LA; Martínez Castillo, M; Medina-Aguilar, R; Villegas Sepúlveda, N	1
Kala, R; Tollefsbol, TO	1
Andrisani, O; Buvala, H; Camarillo, I; Flanagan, JM; Flower, K; Kuang, S; Kurzava, L; Lubecka, K; Stefanska, B; Suderman, M; Teegarden, D; Zhang, H	1
Castillo-Pichardo, L; Dharmawardhane, S; Gerena, Y; Rivera Rivera, A	1
He, G; Li, C; Tang, C	1
Bhat, HK; Bhat, NK; Chatterjee, A; Padhye, S; Ronghe, A	1
Astudillo-de la Vega, H; Flores-Pérez, A; García Mena, J; Gariglio, P; Hernández Juárez, J; López-Camarillo, C; Marchat, LA; Medina-Aguilar, R; Pérez-Plasencia, C; Rodríguez Cuevas, S; Ruíz-García, E	1
Cardoso, SM; Deus, CM; Magalhães-Novais, S; Moreira, AC; Oliveira, PJ; Sardão, VA; Serafim, TL; Vilaça, A	1
Dong, MH; Du, C; Jin, L; Ren, YJ; Xu, C	1
Dongari, N; Kubátová, A; Kusler, K; Leadbetter, M; Liyanage, D; Novikov, A; Rousova, J; Sauter, ER; Zhang, KK	1
Baer-Dubowska, W; Licznerska, B; Sobierajska, H; Szaefer, H; Wierzchowski, M	1
Bennett, LL; Mondal, A	1
Amici, A; Andreani, C; Bartolacci, C; Marchini, C	1
Cho, DY; Cho, KH; Choe, SR; Kang, J; Kim, YN; Lee, HY; Park, CG	1
Agrawal, AK; Dora, CP; Garg, T; Jain, S; Kushwah, V; Thanki, K	1
Lim, LH; Mustafa, FB; Ng, FS; Nguyen, TH; Pervaiz, S	1
Hsieh, TC; Wu, JM	1
Cao, L; Chen, W; Deng, CX; Finkel, T; Gardner, K; Hung, MC; Kim, HS; Lee, MH; Luhasen, T; Man, YG; Vassilopoulos, A; Wang, RH; Xiao, C; Xu, X; Zheng, Y	1
Chung, MH; Kang, JS; Kim, HS; Kim, JE; Kim, Y; Lee, CS; Lee, JW; Lee, SA; Shin, YJ; Won, C; Ye, SK	1
Cavalieri, EL; Lu, F; Rogan, EG; Saeed, M; Wang, C; Zahid, M	1
Bae, I; Baruchello, R; Dakshanamurthy, S; Daniele, S; Grisolia, G; Hong, YB; Kang, HJ; Kim, HJ; Rondanin, R; Rosen, EM	1
Haslinger, E; Jäger, W; Kunert, O; Miksits, M; Svoboda, M; Szekeres, T; Thalhammer, T; Wlcek, K	1
Albanito, L; Andò, S; Dolce, V; Forti, L; Gabriele, B; Iacopetta, D; Lappano, R; Madeo, A; Maggiolini, M; Pezzi, V; Plastina, P; Rosano, C; Stivala, LA	1
Athar, M; Back, JH; Bickers, DR; Kim, AL; Kopelovich, L	1
Ellinger, I; Falany, CN; Jaeger, W; Miksits, M; Stefanzl, G; Svoboda, M; Szekeres, T; Thalhammer, T; Wlcek, K	1
Horiguchi, H; Kayama, F; Oguma, E; Sakamoto, T	1
Cavalieri, EL; Rogan, EG	1
Fukui, M; Yamabe, N; Zhu, BT	1
Alfaras, I; Alvarez, AI; Juan, ME; Merino, G; Pérez, M; Planas, JM; Prieto, JG	1
Anant, S; Houchen, CW; Ramalingam, S; Subramaniam, D	1
Bednarek, A; Fabianowska-Majewska, K; Rudnicka, K; Stefanska, B	1
Jue, DM; Kim, S; Na, HK; Park, SA; Son, PS; Surh, YJ	1
Lamore, SD; Papoutsis, AJ; Romagnolo, DF; Selmin, OI; Wondrak, GT	1
Anisimova, NY; Gakh, AA; Kiselevsky, MV; Krasavin, MY; Rufanov, KA; Sadovnikov, SV; Sosnov, AV; Stankov, IN; Yudin, MV	1
Macpherson, L; Matthews, J	1
Basaran, A; Bayram, B; Cosan, DT; Degirmenci, I; Gunes, HV; Musmul, A; Soyocak, A	1
Beseler, C; Cavalieri, EL; Rogan, EG; Saeed, M; Zahid, M	1
Eng, C; He, X; Orloff, M; Wang, Y; Zhu, J	1
Cao, D; Chiba, T; Endo, M; Fujioka, T; Fukuda, K; Hirota, S; Kashiwaba, M; Kobayashi, A; Koeda, K; Liu, W; Mo, YY; Okuda, H; Pai, SK; Pandey, PR; Sugai, T; Suzuki, K; Tanji, S; Wakabayashi, G; Watabe, K; Watabe, M; Wilber, AC; Xing, F	1
Alkhalaf, M; Khan, I; Mehdawi, H	1
Hsieh, TC; John Bennett, D; Wong, C; Wu, JM	1
Balapure, AK; Chaturvedi, R; Garg, VK; Kumar, S; Mitra, K; Nigam, M; Ranjan, V; Rath, SK; Shankar, R; Sharma, R; Sharma, S; Singh, N; Zaidi, D	1
Brown, D; Davis, FB; Davis, PJ; Drusano, GL; Kulawy, R; Landersdorfer, CB; Lim, CU; Lin, C; Lin, HY; Lin, S; London, D; Louie, A; Meng, R; Mousa, SA; Queimado, L; Tang, HY; Van Scoy, B	1
Callaghan, S; Lu, X; Park, DS; Shi, Y; Troup, S; Xing, Y; Yang, S; Yang, X	1
Betancourt, AM; Jenkins, S; Lamartiniere, CA; Wang, J	1
Andò, S; De Amicis, F; Fuqua, SA; Giordano, F; Panno, ML; Pellegrino, M; Tramontano, D; Vivacqua, A	1
Acierno, R; Giovinazzo, G; Lorusso, V; Maffia, M; Santino, A; Siciliano, C; Storelli, C; Tinelli, A; Valente, CM; Vergara, D	1
Bednarek, A; Fabianowska-Majewska, K; Salamé, P; Stefanska, B	1
Cheng, AC; Chiou, YS; Huang, H; Lee, MF; Pan, MH	1
Arnaud, O; Di Pietro, A; Falson, P; Ferreira-Pereira, A; Gauthier, C; Guitton, J; Pereira Rangel, L; Rocha, ME; Spatafora, C; Tringali, C; Valdameri, G; Winnischofer, SM	1
Anania, C; Calvanese, M; Di Franco, R; Di Gennaro, D; Guida, C; Manzo, R; Murino, P; Ravo, V	1
Chen, YC; Kliethermes, B; Qin, W; Rottinghaus, GE; Sauter, ER; Zhang, K; Zhu, W	1
Casanova, F; da Costa, DC; da Silva, JL; Fialho, E; Quarti, J; Ramos, CA	1
Alvarez-Rios, E; Diaz-Chavez, J; Garcia-Mena, J; Garcia-Villa, E; Gariglio, P; Herrera, LA; Hidalgo-Miranda, A; Leon-Galicia, I; Uribe-Figueroa, L	1
Leporatti, S; Lvov, YM; Vergaro, V	1
Castillo-Pichardo, L; Dharmawardhane, SF	1
Casanova, FA; Dos Santos, PS; Ferraz da Costa, DC; Fialho, E; Malheiros, MS; Quarti, J; Sanches, D; Silva, JL	1
Fukuda, K; Hirota, S; Iiizumi-Gairani, M; Mo, YY; Pai, SK; Pandey, PR; Sharma, S; Watabe, K; Watabe, M; Xing, F	1
El Gendy, MA; El-Kadi, AO; Korashy, HM; Maayah, ZH	1
Castillo-Pichardo, L; Cubano, LA; Dharmawardhane, S	1
Aggarwal, BB; Banerjee, S; Bueso-Ramos, C	1
Alvarez-Barrientos, A; Fernandez-Salguero, PM; Mulero-Navarro, S; Pozo-Guisado, E; Santiago-Josefat, B	1
Azios, NG; Brownson, DM; Dharmawardhane, SF; Fuqua, BK; Mabry, TJ	1
Lehmann, L; Metzler, M; Schmitt, E; Stopper, H	1
Gehm, BD; Horiguchi, J; Jameson, JL; Jordan, VC; Levenson, AS; Pearce, ST; Simons, LA; Ward, JE	1
Beck, V; Eder, R; Jungbauer, A; Klinge, CM; Risinger, KE; Watts, MB	1
Welsh, J; Wietzke, JA	1
Alkhalaf, M; El-Mowafy, AM	1
Bernard-Gallon, DJ; Bignon, YJ; Chalabi, N; Communal, Y; Fustier, P; Le Corre, L; Vissac-Sabatier, C	1
Ghidoni, R; Sacchi, N; Sala, G; Scarlatti, F; Signorelli, P; Somenzi, G	1
Choi, BT; Choi, YH; Kim, YA; Lee, YT; Park, DI; Park, KY; Rhee, SH	1
Debatin, KM; Fulda, S	1
Fernández-Salguero, PM; Lorenzo-Benayas, MJ; Pozo-Guisado, E	1
Amundsen, BM; Cushman, M; Gehm, BD; Jameson, JL; Jordan, VC; Lee, EJ; Levenson, AS; Liu, H	1
Bernard-Gallon, D; Bignon, YJ; Chalabi, N; Fustier, P; Le Corre, L	1
Aregullin, M; Berry, JP; Flanders, JA; Laux, MT; Rodriguez, E	1
Cao, HJ; Davis, FB; Davis, PJ; Lin, HY; Tang, HY; Zhang, S	1
Bianco, NR; Chaplin, LJ; Montano, MM	1
Schneider, J; Ward, EC; Welsh, J; Wietzke, JA	1
Ferraroni, M; Ghidoni, R; La Vecchia, C; Levi, F; Lucchini, F; Pasche, C	1
Bernard-Gallon, DJ; Bignon, YJ; Chalabi, N; Delort, L; Le Corre, L	2
Azios, NG; Dharmawardhane, SF	1
Asmerom, Y; De León, DD; Vyas, S	2
Alexaki, VI; Castanas, E; Kampa, M; Nifli, AP; Notas, G	1
Dabrosin, C; Garvin, S; Ollinger, K	1
Adamo, R; Bonmassar, E; Cottarelli, A; Falchetti, R; Franzese, O; Fuggetta, MP; Lanzilli, G; Ravagnan, G; Serafino, A; Tricarico, M; Turriziani, M	1
Choi, HK; Kang, KW; Yang, JW	1
Chan, FL; Chen, S; Lee, KW; Leung, LK; Wang, Y	1
Battaglia, C; Bicciato, S; Bonnal, R; De Bellis, G; Ghidoni, R; Mangano, E; Mattioli, M; Mezzelani, A; Milanesi, L; Peano, C; Scarlatti, F; Severgnini, M; Viti, F	1
Feng, L; Jin, J; Tao, WY; Yan, T; Zhang, LF	2
Bergh, J; Cao, HJ; Davis, FB; Davis, PJ; Keating, T; Krisa, S; Lansing, L; Lin, HY; Merillon, JM; Quackenbush, S; Shih, A; Tang, HY; Vitrac, X	1
Cao, HJ; Davis, FB; Davis, PJ; Lin, HY; Shih, A; Tang, HY	1
Dogliotti, E; Dolfini, E; Erba, E; Ghidoni, R; Roncoroni, L; Sacchi, N; Sala, G	1
Ge, H; Guo, BS; He, B; Wang, BY; Wang, CQ; Zhang, JF	1
Beijnen, JH; Borst, P; Breedveld, P; Cipriani, G; Dahlhaus, F; de Wolf, CJ; Jansen, G; Kuil, A; Pluim, D; Scheffer, GL; Schellens, JH; van Eijndhoven, MA	1
Li, F; Li, Y; Liu, J; Liu, X; Wang, Y; Xing, K; Yao, L	1
Azios, NG; Cammer, M; Cubano, LA; Dharmawardhane, SF; Harris, M; Krishnamoorthy, L	1
Bosetti, C; La Vecchia, C	1
Benitez, DA; Castellón, E; Clementi, M; Fernandez-Salguero, PM; Pozo-Guisado, E	1
Kocsis, Z; Marcsek, ZL; Szende, B; Tompa, A	1
Alkhalaf, M	2
Chiang, EP; Sun, YC; Tang, FY	1
Albert, DM; Darjatmoko, SR; Polans, AS; Sareen, D	1
Kramer, MP; Maurer, M; Wesierska-Gadek, J	1
Aust, S; Jaeger, W; Miksits, M; Murias, M; Spatzenegger, M; Szekeres, T; Thalhammer, T	1
Al-Attyiah, R; Ali, A; Alkhalaf, M; El-Mowafy, A; Rachid, O; Renno, W	1
Chang, HY; Chang, KJ; Hsu, CH; Huang, TC; Juan, HF; Kuo, WH	1
Gossage, RA; Haddadi, A; Lai, R; Lavasanifar, A; Ma, Z; Molavi, O	1
Bader, Y; Erker, T; Fritzer-Szekeres, M; Gollinger, M; Handler, N; Huber, D; Jäger, W; Kopp, B; Krupitza, G; Madlener, S; Maier, S; Popescu, R; Saiko, P; Stark, N; Strasser, S; Szakmary, A; Szekeres, T; Tentes, I	1
Almaguel, F; De León, D; De León, M; Moretta, D; Singh, SK; Wall, NR	1
Chen, KS; Chen, NC; Hsieh, HS; Su, YC; Tang, FY	1
Beau, I; Codogno, P; Ghidoni, R; Maffei, R; Scarlatti, F	1
Ali, MF; Cavalieri, EL; Gaikwad, NW; Lu, F; Rogan, EG; Saeed, M; Yang, L; Zahid, M	1
Almaguel, F; De León, DD; De León, M; Moretta, D; Singh, SK	1
Jia, L; Kline, K; Sanders, BG; Snyder, RM; Yu, W	1
Leung, LK; Wang, Y; Ye, L	1
Chien, PY; Gehm, BD; Jameson, JL; McAndrews, JM	1
Mgbonyebi, OP; Russo, IH; Russo, J	1
Kopp, P	1
Chawdhury, SH; Clément, MV; Hirpara, JL; Pervaiz, S	1
Lu, R; Serrero, G	2
Backer, JM; Burfeind, P; Darzynkiewicz, Z; Hsieh, TC; Laud, K; Traganos, F; Wu, JM	1
Gottlieb, N	1
Baumgartner, G; Hamilton, G; Hejna, M; Hoffmann, O; Mallinger, R; Raderer, M; Ulsperger, E	1
Bakogeorgou, E; Castanas, E; Damianaki, A; Gemetzi, C; Hatzoglou, A; Kampa, M; Kouroumalis, E; Martin, PM; Notas, G; Panagiotou, S	1
Huber, J	1
Hioki, K; Kiyozuka, Y; Nakagawa, H; Senzaki, H; Shikata, N; Tsubura, A; Uemura, Y	1
Diamandis, EP; Goldberg, DM; Grass, L; Levesque, M; Soleas, GJ	1
Lee, JE; Safe, S	1
Bruggisser, R; Jundt, G; Schaffner, W; Tullberg-Reinert, H; von Daeniken, K	1

Reviews

23 review(s) available for resveratrol and Breast Neoplasms

Article	Year
Combination Therapy Using Polyphenols: An Efficient Way to Improve Antitumoral Activity and Reduce Resistance. International journal of molecular sciences, 2022, Sep-06, Volume: 23, Issue:18 Topics: Anti-Bacterial Agents; Antineoplastic Agents; beta Catenin; Breast Neoplasms; Catechin; Curcumin; Cytostatic Agents; Doxorubicin; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fluorouracil; Humans; Liver Neoplasms; Polyphenols; Receptors, Estrogen; Resveratrol	2022
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action. Cellular and molecular life sciences : CMLS, 2022, Oct-04, Volume: 79, Issue:11 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Docetaxel; Doxorubicin; Female; Humans; Paclitaxel; Polyphenols; Resveratrol; Stilbenes; Tumor Microenvironment; Water	2022
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12 Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult	2022
Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2020, Volume: 68 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Proliferation; Curcumin; Female; Gene Expression Regulation, Neoplastic; Genistein; Humans; MicroRNAs; Plant Extracts; Resveratrol	2020
Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression. Biomolecules, 2020, 01-27, Volume: 10, Issue:2 Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chalcones; Curcumin; Disease Progression; Endothelial Cells; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Oxygen; Phytochemicals; Phytotherapy; Prognosis; Reactive Oxygen Species; Resveratrol; Signal Transduction	2020
Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer. Nutrients, 2020, Mar-13, Volume: 12, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Catechin; Chromatin; DNA Modification Methylases; Epigenesis, Genetic; Female; Flavonoids; Genes, Tumor Suppressor; Genistein; Humans; Polyphenols; Resveratrol	2020
Synthesis and biological evaluation of resveratrol derivatives with anti-breast cancer activity. Archiv der Pharmazie, 2020, Volume: 353, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Molecular Structure; Resveratrol	2020
Nutraceuticals in the Mediterranean Diet: Potential Avenues for Breast Cancer Treatment. Nutrients, 2021, Jul-26, Volume: 13, Issue:8 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Cycle Checkpoints; Diet, Mediterranean; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Inflammation; Polyphenols; Resveratrol; Retinoids	2021
Resveratrol as MDR reversion molecule in breast cancer: An overview. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2017, Volume: 103 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; DNA Repair; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Female; Humans; Inactivation, Metabolic; Phytoestrogens; Resveratrol; Stilbenes	2017
The Role of Oxidative Stress Modulators in Breast Cancer. Current medicinal chemistry, 2018, Volume: 25, Issue:33 Topics: Animals; Ascorbic Acid; Breast Neoplasms; Carotenoids; Female; Humans; Melatonin; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Stilbenes; Tocopherols	2018
Targeting cancer stem cells and signaling pathways by resveratrol and pterostilbene. BioFactors (Oxford, England), 2018, Volume: 44, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Communication; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Proteins; Neoplastic Stem Cells; Resveratrol; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays	2018
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer. International journal of molecular sciences, 2019, Mar-03, Volume: 20, Issue:5 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Prostatic Neoplasms; Receptors, Steroid; Resveratrol; Signal Transduction	2019
Resveratrol and other dietary polyphenols are inhibitors of estrogen metabolism in human breast cancer cells. The Journal of steroid biochemistry and molecular biology, 2019, Volume: 190 Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Proliferation; Dietary Supplements; Estrogen Receptor alpha; Estrogens; Female; Humans; Polyphenols; Resveratrol	2019
Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. Seminars in cancer biology, 2016, Volume: 40-41 Topics: Animals; Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Molecular Targeted Therapy; Plant Extracts; Resveratrol; Stilbenes	2016
Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment. Mini reviews in medicinal chemistry, 2016, Volume: 16, Issue:9 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Proliferation; Female; Humans; Resveratrol; Stilbenes	2016
Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer. Current protein & peptide science, 2018, Volume: 19, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Breast; Breast Neoplasms; Cell Proliferation; Female; Humans; Resveratrol; Stilbenes; Wine	2018
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Archives of biochemistry and biophysics, 2009, Jun-15, Volume: 486, Issue:2 Topics: Anticarcinogenic Agents; Breast Neoplasms; Cathepsins; Cell Cycle; Cell Division; Female; Humans; Inflammation; Leukemia; Lymphoma; Male; Neoplasms; Prostatic Neoplasms; Resveratrol; Safety; Stilbenes; Transcription Factors	2009
Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future oncology (London, England), 2010, Volume: 6, Issue:1 Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Breast Neoplasms; DNA Adducts; Estrogens; Female; Humans; Male; Neoplasms; Resveratrol; Stilbenes	2010
Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini reviews in medicinal chemistry, 2010, Volume: 10, Issue:5 Topics: AC133 Antigen; Antigens, CD; Breast Neoplasms; Colonic Neoplasms; Curcumin; Female; Glycoproteins; Hedgehog Proteins; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides; Protein Serine-Threonine Kinases; Receptors, Notch; Resveratrol; Signal Transduction; Stilbenes	2010
Endocrine-active chemicals in mammary cancer causation and prevention. The Journal of steroid biochemistry and molecular biology, 2012, Volume: 129, Issue:3-5 Topics: Animals; Anticarcinogenic Agents; Benzhydryl Compounds; Breast; Breast Neoplasms; Diethylstilbestrol; Endocrine Disruptors; Estrogens, Non-Steroidal; Female; Genistein; Humans; Phenols; Polychlorinated Dibenzodioxins; Resveratrol; Stilbenes	2012
Resveratrol and breast cancer chemoprevention: molecular mechanisms. Molecular nutrition & food research, 2005, Volume: 49, Issue:5 Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Division; Humans; Phosphatidylinositol 3-Kinases; Phytoestrogens; Resveratrol; Signal Transduction; Stilbenes; Xenobiotics	2005
Diet and cancer risk in Mediterranean countries: open issues. Public health nutrition, 2006, Volume: 9, Issue:8A Topics: Breast Neoplasms; Case-Control Studies; Diet, Mediterranean; Digestive System Neoplasms; Flavonoids; Humans; Italy; Mediterranean Region; Micronutrients; Resveratrol; Risk Factors; Stilbenes	2006
[Phytoestrogens and SERMS, alternatives to classical hormone therapy?]. Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:10 Topics: Aged; Anticarcinogenic Agents; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Genistein; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Postmenopause; Receptors, Estrogen; Resveratrol; Selective Estrogen Receptor Modulators; Stilbenes	2000

Trials

3 trial(s) available for resveratrol and Breast Neoplasms

Article	Year
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12 Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult	2022
Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2007, Aug-27, Volume: 119, Issue:34 Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult	2007
Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutrition and cancer, 2012, Volume: 64, Issue:3 Topics: Breast; Breast Neoplasms; Cyclin D2; Dinoprostone; DNA Methylation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Middle Aged; Promoter Regions, Genetic; Resveratrol; Risk Factors; Stilbenes; Tumor Suppressor Proteins	2012

Other Studies

248 other study(ies) available for resveratrol and Breast Neoplasms

Article	Year
Phenolic constituents of the rhizomes of the Thai medicinal plant Belamcanda chinensis with proliferative activity for two breast cancer cell lines. Journal of natural products, 2005, Volume: 68, Issue:3 Topics: Breast Neoplasms; Cell Proliferation; Female; Humans; Iridaceae; Isoflavones; Molecular Structure; Phenols; Plants, Medicinal; Resveratrol; Rhizome; Stilbenes; Thailand; Tumor Cells, Cultured	2005
Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells. Journal of medicinal chemistry, 2005, Nov-03, Volume: 48, Issue:22 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Ceramides; Drug Screening Assays, Antitumor; Female; Humans; Resveratrol; Stilbenes; Structure-Activity Relationship	2005
Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. The Journal of biological chemistry, 2007, Jul-06, Volume: 282, Issue:27 Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Breast Neoplasms; Cell Line, Tumor; Estrogen Replacement Therapy; Estrogens; Female; Forkhead Transcription Factors; Gene Expression Regulation, Enzymologic; Humans; Mice; Osteoporosis, Postmenopausal; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Resveratrol; Risk Factors; src-Family Kinases; Stilbenes; Transforming Growth Factor beta	2007
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nature chemical biology, 2009, Volume: 5, Issue:2 Topics: Breast Neoplasms; Drug Design; Enzyme Inhibitors; Humans; Isoenzymes; Neoplasm Invasiveness; Phospholipase D	2009
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties. Bioorganic & medicinal chemistry, 2010, Sep-15, Volume: 18, Issue:18 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Combinatorial Chemistry Techniques; Female; Heterocyclic Compounds; Humans; Resveratrol; Stilbenes; Vasodilator Agents	2010
Novel Aza-resveratrol analogs: synthesis, characterization and anticancer activity against breast cancer cell lines. Bioorganic & medicinal chemistry letters, 2013, Feb-01, Volume: 23, Issue:3 Topics: Aza Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Estrogen Receptor alpha; Female; Gene Expression Regulation; Humans; Hydrogen Bonding; Models, Molecular; Molecular Structure; Protein Binding; Resveratrol; Stilbenes	2013
Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines. Bioorganic & medicinal chemistry letters, 2013, Sep-01, Volume: 23, Issue:17 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Resveratrol; Stilbenes; Thiazolidinediones	2013
Novel Hybrid Conjugates with Dual Suppression of Estrogenic and Inflammatory Activities Display Significantly Improved Potency against Breast Cancer. Journal of medicinal chemistry, 2018, 09-27, Volume: 61, Issue:18 Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Humans; Inflammation; Ligands; Macrophages; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Molecular Structure; NF-kappa B; Protein Conformation; Resveratrol; Signal Transduction; Structure-Activity Relationship; Sulfones	2018
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors. European journal of medicinal chemistry, 2021, Nov-15, Volume: 224 Topics: Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Sulfonamides	2021
Comparison of the Effects of Resveratrol and Its Derivatives on the Radiation Response of MCF-7 Breast Cancer Cells. International journal of molecular sciences, 2021, Sep-01, Volume: 22, Issue:17 Topics: Breast Neoplasms; Female; Glucosides; Humans; MCF-7 Cells; Radiation Tolerance; Radiation, Ionizing; Resveratrol; Stilbenes	2021
Pro-Oxidant Effect of Resveratrol on Human Breast Cancer MCF-7 Cells is Associated with CK2 Inhibition. Nutrition and cancer, 2022, Volume: 74, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Casein Kinase II; Female; Humans; MCF-7 Cells; Reactive Oxygen Species; Resveratrol	2022
Antiproliferative, antimigratory, and prooxidative potential of novel platinum(IV) complexes and resveratrol on breast cancer (MDA-MB-231) and choriocarcinoma (JEG-3) cell lines. Drug development research, 2022, Volume: 83, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Choriocarcinoma; Cisplatin; Female; Humans; Platinum; Resveratrol	2022
Integrative investigation of the TF-miRNA coregulatory network involved in the inhibition of breast cancer cell proliferation by resveratrol. FEBS open bio, 2022, Volume: 12, Issue:2 Topics: Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; MicroRNAs; Resveratrol; Transcription Factors	2022
Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2022, Volume: 24, Issue:5 Topics: Breast Neoplasms; Cell Line, Tumor; Cisplatin; Female; Humans; Interleukin-6; Macrophages; Resveratrol; Tumor Microenvironment	2022
Resveratrol drives cancer cell senescence Food & function, 2022, Mar-21, Volume: 13, Issue:6 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cellular Senescence; DNA Damage; Endoplasmic Reticulum Stress; GTPase-Activating Proteins; Humans; Lung Neoplasms; MAP Kinase Signaling System; MCF-7 Cells; Mitochondria; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Resveratrol; Signal Transduction; Sirtuin 1; Tumor Suppressor Proteins; Up-Regulation	2022
Milk-Derived Exosomes as Nanocarriers to Deliver Curcumin and Resveratrol in Breast Tissue and Enhance Their Anticancer Activity. International journal of molecular sciences, 2022, Mar-05, Volume: 23, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Curcumin; Exosomes; Female; Humans; Milk; Polyphenols; Rats; Resveratrol	2022
Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux. Biochemical pharmacology, 2022, Volume: 199 Topics: Animals; Antineoplastic Agents; Autophagy; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Mice; Mice, SCID; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; Xenograft Model Antitumor Assays	2022
Dual Vinorelbine bitartrate and Resveratrol loaded polymeric aqueous core nanocapsules for synergistic efficacy in breast cancer. Journal of microencapsulation, 2022, Volume: 39, Issue:4 Topics: Breast Neoplasms; Female; Humans; Nanocapsules; Polymers; Resveratrol; Vinorelbine; Water	2022
Higher efficacy of resveratrol against advanced breast cancer organoids: A comparison with that of clinically relevant drugs. Phytotherapy research : PTR, 2022, Volume: 36, Issue:8 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Organoids; Resveratrol	2022
Transpapillary iontophoretic delivery of resveratrol loaded transfersomes for localized delivery to breast cancer. Biomaterials advances, 2022, Volume: 140 Topics: Administration, Oral; Animals; Breast Neoplasms; Drug Delivery Systems; Female; Humans; Iontophoresis; Rats; Resveratrol; Swine	2022
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway. Experimental cell research, 2022, 11-01, Volume: 420, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; DNA; Endonucleases; Humans; Mice; Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Recombinational DNA Repair; Resveratrol	2022
Targeted delivery and apoptosis induction activity of peptide-transferrin targeted mesoporous silica encapsulated resveratrol in MCF-7 cells. The Journal of pharmacy and pharmacology, 2023, Jan-31, Volume: 75, Issue:1 Topics: Apoptosis; Breast Neoplasms; Cathepsin B; Drug Carriers; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Nanoparticles; Peptides; Porosity; Resveratrol; Silicon Dioxide; Transferrin	2023
Downregulation of MDM2 by small interference RNA induces apoptosis and sensitizes MCF-7 breast cells to resveratrol. Chemical biology & drug design, 2023, Volume: 101, Issue:5 Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; MCF-7 Cells; Mice; Proto-Oncogene Proteins c-mdm2; Resveratrol; RNA Interference; RNA, Small Interfering	2023
Metformin enhances anti-cancer properties of resveratrol in MCF-7 breast cancer cells via induction of apoptosis, autophagy and alteration in cell cycle distribution. Biochemical and biophysical research communications, 2023, 02-12, Volume: 644 Topics: Autophagy; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Diabetes Mellitus, Type 2; Female; G1 Phase Cell Cycle Checkpoints; Humans; Male; MCF-7 Cells; Metformin; Resveratrol	2023
Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International journal of molecular sciences, 2023, Jan-21, Volume: 24, Issue:3 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Globins; Gold; Humans; Metal Nanoparticles; Nerve Tissue Proteins; Neuroglobin; Paclitaxel; Prodrugs; Resveratrol	2023
Efficacy of resveratrol against breast cancer and hepatocellular carcinoma cell lines. Saudi medical journal, 2023, Volume: 44, Issue:3 Topics: Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Female; Humans; Liver Neoplasms; Resveratrol	2023
The anti-cancer effect of resveratrol nano-encapsulated supplements against breast cancer via the regulation of oxidative stress. Journal of microencapsulation, 2023, Volume: 40, Issue:5 Topics: Antioxidants; Breast Neoplasms; Female; Humans; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol	2023
Design of Sonosensitizers Integrated with Resveratrol Motif for Synergetic Sonodynamic Therapy and Nuclear Factor Kappa B Transcription Suppression of Breast Cancer. Journal of medicinal chemistry, 2023, 05-11, Volume: 66, Issue:9 Topics: Animals; Breast Neoplasms; Female; Humans; MCF-7 Cells; Mice; Neoplasms; NF-kappa B; Resveratrol; Ultrasonic Therapy	2023
Design of rapamycin and resveratrol coloaded liposomal formulation for breast cancer therapy. Nanomedicine (London, England), 2023, Volume: 18, Issue:10 Topics: Antioxidants; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Liposomes; Resveratrol; Sirolimus	2023
Resveratrol and 3,3'-Diindolylmethane Differentially Regulate Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha Activity through Multiple Transcriptomic Targets in MCF-7 Human Breast Cancer Cells. International journal of molecular sciences, 2023, Sep-26, Volume: 24, Issue:19 Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Female; Humans; MCF-7 Cells; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Resveratrol; Signal Transduction; Transcriptome	2023
Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers. International journal of nanomedicine, 2019, Volume: 14 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Shape; Cell Survival; Endocytosis; Female; Gold; Humans; Inhibitory Concentration 50; Male; Metal Nanoparticles; Pancreatic Neoplasms; Particle Size; Polyphenols; Prostatic Neoplasms; Resveratrol; Spectrophotometry, Ultraviolet; Treatment Outcome	2019
Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression. Oncology, 2019, Volume: 97, Issue:6 Topics: Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Movement; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Female; Humans; NAV1.5 Voltage-Gated Sodium Channel; Resveratrol	2019
Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes. Pharmacological reports : PR, 2019, Volume: 71, Issue:6 Topics: Breast Neoplasms; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Enzyme Induction; Epithelial Cells; Female; Humans; MCF-7 Cells; Resveratrol; Stilbenes	2019
Increase in fatty acids and flotillins upon resveratrol treatment of human breast cancer cells. Scientific reports, 2019, Sep-27, Volume: 9, Issue:1 Topics: Antioxidants; Breast Neoplasms; Cell Membrane; Cell Survival; Fatty Acids; Humans; MCF-7 Cells; Membrane Microdomains; Membrane Proteins; Resveratrol	2019
The Cytotoxicity Effect of Resveratrol: Cell Cycle Arrest and Induced Apoptosis of Breast Cancer 4T1 Cells. Toxins, 2019, 12-13, Volume: 11, Issue:12 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Resveratrol	2019
27-Hydroxycholesterol-induced EndMT acts Cancer biology & medicine, 2020, 02-15, Volume: 17, Issue:1 Topics: Acetylation; Benzoates; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Endothelium, Vascular; Epithelial-Mesenchymal Transition; Female; Human Umbilical Vein Endothelial Cells; Humans; Hydroxycholesterols; Nitrobenzenes; Pyrazolones; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Tumor Microenvironment	2020
Resveratrol Induces Apoptosis and Attenuates Proliferation of MCF-7 Cells in Combination with Radiation and Hyperthermia. Current molecular medicine, 2021, Volume: 21, Issue:2 Topics: Antioxidants; Apoptosis; Breast Neoplasms; Cell Proliferation; Combined Modality Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Hyperthermia, Induced; Resveratrol; Tumor Cells, Cultured; X-Rays	2021
Resveratrol, Curcumin and Piperine Alter Human Glyoxalase 1 in MCF-7 Breast Cancer Cells. International journal of molecular sciences, 2020, Jul-24, Volume: 21, Issue:15 Topics: Alkaloids; Benzodioxoles; Breast Neoplasms; Curcumin; Female; Humans; Lactoylglutathione Lyase; MCF-7 Cells; Membrane Potential, Mitochondrial; Piperidines; Polyunsaturated Alkamides; Resveratrol	2020
Effects of Notch signaling components from breast cancer cells treated in culture with resveratrol. Research in veterinary science, 2020, Volume: 132 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Humans; Receptor, Notch1; Resveratrol	2020
Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells. International journal of molecular sciences, 2020, Oct-21, Volume: 21, Issue:20 Topics: Antineoplastic Agents; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Female; HEK293 Cells; Humans; Imines; Molecular Docking Simulation; Poly-ADP-Ribose Binding Proteins; Resveratrol; Topoisomerase I Inhibitors	2020
Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro-In Silico Model. Oxidative medicine and cellular longevity, 2020, Volume: 2020 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Doxorubicin; Female; Humans; Prognosis; Resveratrol; Tumor Cells, Cultured	2020
Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells. Nanotheranostics, 2021, Volume: 5, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Drug Carriers; Female; Humans; MCF-7 Cells; Micelles; Resveratrol	2021
Quercetin 3,5,7,3',4'-pentamethyl ether from Kaempferia parviflora directly and effectively activates human SIRT1. Communications biology, 2021, 02-19, Volume: 4, Issue:1 Topics: Allosteric Regulation; Antineoplastic Agents, Phytogenic; Binding Sites; Breast Neoplasms; Enzyme Activation; Enzyme Activators; Female; Humans; MCF-7 Cells; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Protein Conformation, alpha-Helical; Quercetin; Resveratrol; Sirtuin 1; Zingiberaceae	2021
Mechanism underlying resveratrol's attenuation of paclitaxel cytotoxicity in human breast cancer cells: Role of the SIRT1-FOXO1-HER3 signaling pathway. Cancer treatment and research communications, 2021, Volume: 28 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Forkhead Box Protein O1; Humans; Paclitaxel; Protective Agents; Receptor, ErbB-3; Resveratrol; Signal Transduction; Sirtuin 1	2021
A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth. International journal of molecular sciences, 2021, May-17, Volume: 22, Issue:10 Topics: Apoptosis; Biological Availability; Breast; Breast Neoplasms; Cell Cycle; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Resveratrol	2021
Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation. Toxicology and applied pharmacology, 2017, 06-15, Volume: 325 Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents, Phytogenic; Apigenin; Breast Neoplasms; Cell Proliferation; Chemokine CXCL12; Diet; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Isoflavones; MCF-7 Cells; Nerve Tissue Proteins; Neurites; Neurogenesis; PC12 Cells; Pheochromocytoma; Phytoestrogens; Rats; Response Elements; Resveratrol; Selective Estrogen Receptor Modulators; Stilbenes; Transcription, Genetic; Transfection; Zearalenone	2017
A novel resveratrol-salinomycin combination sensitizes ER-positive breast cancer cells to apoptosis. Pharmacological reports : PR, 2017, Volume: 69, Issue:4 Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Humans; Pyrans; Receptors, Estrogen; Resveratrol; Signal Transduction; Stilbenes; Wnt Proteins	2017
Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells. Apoptosis : an international journal on programmed cell death, 2017, Volume: 22, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Flow Cytometry; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; MCF-7 Cells; Pyrans; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Stem Cell Assay	2017
Maternal Resveratrol Treatment Reduces the Risk of Mammary Carcinogenesis in Female Offspring Prenatally Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Hormones & cancer, 2017, Volume: 8, Issue:5-6 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Hormones; Male; Maternal Exposure; Polychlorinated Dibenzodioxins; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol; Stilbenes; Teratogens; Tumor Burden	2017
Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation. PloS one, 2017, Volume: 12, Issue:9 Topics: Adipocytes; Adipokines; Adipose Tissue; Animals; Body Weight; Breast Neoplasms; Cell Cycle; Cell Proliferation; Coculture Techniques; Culture Media, Conditioned; Endocrine System; Female; Humans; Male; MCF-7 Cells; Obesity; Rats; Rats, Zucker; Resveratrol; Stilbenes; Time Factors	2017
Antioxidant activities of novel resveratrol analogs in breast cancer. Journal of biochemical and molecular toxicology, 2018, Volume: 32, Issue:1 Topics: 8-Hydroxy-2'-Deoxyguanosine; Anticarcinogenic Agents; Antioxidants; Breast; Breast Neoplasms; Catechols; Cell Line; Cell Proliferation; Cell Survival; Deoxyguanosine; Dietary Supplements; DNA Damage; Enzyme Induction; Estradiol; Female; Humans; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Reactive Oxygen Species; Resveratrol; Schiff Bases; Signal Transduction; Stilbenes; Superoxide Dismutase	2018
Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells. Molecules (Basel, Switzerland), 2017, Oct-25, Volume: 22, Issue:11 Topics: Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Female; Gene Expression Regulation, Neoplastic; Humans; Lipids; Nanoparticles; Particle Size; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Resveratrol; Stilbenes	2017
Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy. Nanomedicine (London, England), 2017, Volume: 12, Issue:24 Topics: Administration, Oral; Androstadienes; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cross-Linking Reagents; Drug Combinations; Drug Liberation; Female; Glutaral; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Male; Mice; Nanocapsules; Particle Size; Rats, Wistar; Resveratrol; Solubility; Stilbenes; Surface Properties; Tissue Distribution; Zein	2017
Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer. Molecular carcinogenesis, 2018, Volume: 57, Issue:3 Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Models, Animal; Female; Mice, Inbred C57BL; Obesity; Postmenopause; Resveratrol	2018
Intracellular investigation on the differential effects of 4 polyphenols on MCF-7 breast cancer cells by Raman imaging. The Analyst, 2017, Dec-18, Volume: 143, Issue:1 Topics: Apoptosis; Breast Neoplasms; Catechin; Cytochromes c; Cytoplasm; Cytosol; Gallic Acid; Humans; Lipid Metabolism; MCF-7 Cells; Polyphenols; Resveratrol; Tannins	2017
The in vitro radiosensitizer potential of resveratrol on MCF-7 breast cancer cells. Chemico-biological interactions, 2018, Feb-25, Volume: 282 Topics: Antioxidants; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Radiation-Sensitizing Agents; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53	2018
Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer. Nanomedicine (London, England), 2018, Volume: 13, Issue:5 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Caseins; Cell Survival; Drug Carriers; Drug Therapy, Combination; Female; Flavins; Heterocyclic Compounds, 3-Ring; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Mice, Inbred BALB C; Micelles; Monascus; Nanoparticles; Particle Size; Rats; Resveratrol	2018
Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Archives of biochemistry and biophysics, 2018, 04-02, Volume: 643 Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Movement; Cell Proliferation; Enzyme Activation; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neoplasm Invasiveness; Neoplastic Stem Cells; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; SOXB1 Transcription Factors; STAT3 Transcription Factor	2018
Synthetic resveratrol-curcumin hybrid derivative inhibits mitosis progression in estrogen positive MCF-7 breast cancer cells. Toxicology in vitro : an international journal published in association with BIBRA, 2018, Volume: 50 Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Breast Neoplasms; Cell Cycle Proteins; Cell Line; Cell Survival; Curcumin; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Drug Combinations; Estrogens; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; MCF-7 Cells; Mitosis; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; Stilbenes	2018
Resveratrol decreases Rad51 expression and sensitizes cisplatin‑resistant MCF‑7 breast cancer cells. Oncology reports, 2018, Volume: 39, Issue:6 Topics: Breast Neoplasms; Cell Line, Tumor; Cisplatin; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; MCF-7 Cells; Phosphorylation; Rad51 Recombinase; Resveratrol; Stilbenes	2018
Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway. IUBMB life, 2018, Volume: 70, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Movement; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2018
Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes. Life sciences, 2018, Jul-15, Volume: 205 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Survival; Drug Synergism; Female; Humans; MCF-7 Cells; Nitric Oxide; Raloxifene Hydrochloride; Resveratrol; Selective Estrogen Receptor Modulators; Stilbenes	2018
Folate conjugated vs PEGylated phytosomal casein nanocarriers for codelivery of fungal- and herbal-derived anticancer drugs. Nanomedicine (London, England), 2018, Volume: 13, Issue:12 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Caseins; Drug Carriers; Female; Flavins; Folic Acid; Heterocyclic Compounds, 3-Ring; Humans; MCF-7 Cells; Mice; Micelles; Polyethylene Glycols; Polymers; Resveratrol; Xenograft Model Antitumor Assays	2018
Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation. Biochemical pharmacology, 2018, Volume: 155 Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line; Estrogens; Female; Glucuronosyltransferase; Humans; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Resveratrol; Tandem Mass Spectrometry	2018
Physiological Relevance of the Antiproliferative and Estrogenic Effects of Dietary Polyphenol Aglycones versus Their Phase-II Metabolites on Breast Cancer Cells: A Call of Caution. Journal of agricultural and food chemistry, 2018, Aug-15, Volume: 66, Issue:32 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coumarins; Estrogen Antagonists; Estrogens; Female; Humans; Polyphenols; Resveratrol; Stilbenes	2018
Evaluation of the Effect of Resveratrol and Doxorubicin on Cancer biotherapy & radiopharmaceuticals, 2018, Volume: 33, Issue:9 Topics: Animals; Breast Neoplasms; Doxorubicin; Female; Humans; MCF-7 Cells; Mice; Mice, Nude; Resveratrol; Technetium Tc 99m Sestamibi; Tissue Distribution; Xenograft Model Antitumor Assays	2018
Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic⁻Mediating Machinery. International journal of molecular sciences, 2018, Jul-27, Volume: 19, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Drug Therapy, Combination; Epigenesis, Genetic; Female; Grape Seed Extract; Histone Deacetylases; Humans; MCF-7 Cells; Proanthocyanidins; Resveratrol; Stilbenes	2018
Development of Hot Melt Extruded Solid Dispersion of Tamoxifen Citrate and Resveratrol for Synergistic Effects on Breast Cancer Cells. AAPS PharmSciTech, 2018, Volume: 19, Issue:7 Topics: Administration, Oral; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Development; Drug Synergism; Hot Temperature; Humans; MCF-7 Cells; Rats; Rats, Sprague-Dawley; Resveratrol; Spectroscopy, Fourier Transform Infrared; Tamoxifen; X-Ray Diffraction	2018
Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway. Journal of cellular physiology, 2019, Volume: 234, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neuroglobin; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction	2019
Facile Synthesis of Resveratrol Nanogels with Enhanced Fluorescent Emission. Macromolecular bioscience, 2019, Volume: 19, Issue:2 Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Fluorescent Dyes; Humans; MCF-7 Cells; Methacrylates; Nanogels; Polyethylene Glycols; Polyethyleneimine; Resveratrol	2019
Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer. Cancer medicine, 2019, Volume: 8, Issue:3 Topics: Apoptosis; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Doxorubicin; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Gene Expression; Humans; Resveratrol; Signal Transduction; Sirtuin 1	2019
The Contrary Effects of Sirt1 on MCF7 Cells Depend on CD36 Expression Level. The Journal of surgical research, 2019, Volume: 238 Topics: Adrenergic alpha-2 Receptor Agonists; Breast; Breast Neoplasms; CD36 Antigens; Cell Proliferation; Dexmedetomidine; Disease Progression; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Resveratrol; Signal Transduction; Sirtuin 1; Up-Regulation	2019
Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition. Molecules (Basel, Switzerland), 2019, Mar-21, Volume: 24, Issue:6 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Humans; Matrix Metalloproteinases; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays	2019
Resveratrol inhibits the proliferation of estrogen receptor-positive breast cancer cells by suppressing EZH2 through the modulation of ERK1/2 signaling. Cell biology and toxicology, 2019, Volume: 35, Issue:5 Topics: Breast Neoplasms; Butadienes; Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Resveratrol; Signal Transduction	2019
The YB-1/EZH2/amphiregulin signaling axis mediates LPA-induced breast cancer cell invasion. Archives of pharmacal research, 2019, Volume: 42, Issue:6 Topics: Amphiregulin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; MCF-7 Cells; Neoplasm Invasiveness; Phosphorylation; Resveratrol; RNA, Small Interfering; Signal Transduction; Y-Box-Binding Protein 1	2019
Effect of resveratrol on the radiosensitivity of 5-FU in human breast cancer MCF-7 cells. Journal of cellular biochemistry, 2019, Volume: 120, Issue:9 Topics: Breast Neoplasms; Cell Survival; Combined Modality Therapy; Female; Fluorouracil; Gamma Rays; Humans; MCF-7 Cells; Radiation Tolerance; Resveratrol; Spheroids, Cellular	2019
Effects of phytoestrogens on the activity and growth of primary breast cancer cells ex vivo. The journal of obstetrics and gynaecology research, 2019, Volume: 45, Issue:7 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Genistein; Humans; Phytoestrogens; Quercetin; Resveratrol	2019
Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p. Journal of cellular biochemistry, 2019, Volume: 120, Issue:9 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; MicroRNAs; Resveratrol	2019
Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation. Colloids and surfaces. B, Biointerfaces, 2019, Sep-01, Volume: 181 Topics: A549 Cells; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Humans; Lipids; MCF-7 Cells; Nanostructures; Particle Size; Resveratrol; Surface Properties	2019
Resveratrol-Induced Temporal Variation in the Mechanical Properties of MCF-7 Breast Cancer Cells Investigated by Atomic Force Microscopy. International journal of molecular sciences, 2019, Jul-03, Volume: 20, Issue:13 Topics: Breast Neoplasms; Cell Adhesion; Cell Movement; Elastic Modulus; Female; Humans; MCF-7 Cells; Mechanical Phenomena; Microscopy, Atomic Force; Resveratrol	2019
Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9. PloS one, 2019, Volume: 14, Issue:7 Topics: A549 Cells; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MCF-7 Cells; Neoplasm Invasiveness; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Snail Family Transcription Factors; Tumor Suppressor Protein p53; Up-Regulation; Wound Healing	2019
Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor. Molecular nutrition & food research, 2019, Volume: 63, Issue:19 Topics: Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Epigenesis, Genetic; Female; Gene Expression; Gene Knockdown Techniques; Gene Silencing; Homeodomain Proteins; Humans; Neoplasm Invasiveness; NFI Transcription Factors; Promoter Regions, Genetic; Resveratrol; Semaphorin-3A; Stilbenes; Transcription Factors	2019
Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie, 2013, Volume: 95, Issue:6 Topics: Antioxidants; Breast Neoplasms; Cell Survival; Female; Glucose; Humans; MCF-7 Cells; Phosphofructokinase-1; Protein Kinase Inhibitors; Resveratrol; Stilbenes	2013
Anti-estrogenic activity of a human resveratrol metabolite. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2013, Volume: 23, Issue:11 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Clone Cells; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Glucosides; Glucuronides; Humans; MCF-7 Cells; Neoplasm Proteins; Nuclear Receptor Coactivator 2; Peptide Fragments; Phytoestrogens; Recombinant Proteins; Resveratrol; Stereoisomerism; Stilbenes; Sulfates	2013
Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744. British journal of cancer, 2013, Jun-11, Volume: 108, Issue:11 Topics: Breast Neoplasms; Cell Growth Processes; Cell Movement; Down-Regulation; Female; Humans; MCF-7 Cells; MicroRNAs; Peptide Elongation Factor 1; Proto-Oncogene Mas; Resveratrol; RNA, Messenger; Stilbenes; Transfection	2013
Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy. PloS one, 2013, Volume: 8, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; HSP27 Heat-Shock Proteins; Humans; MCF-7 Cells; Proteome; Proteomics; Resveratrol; RNA, Small Interfering; Stilbenes; Tandem Mass Spectrometry	2013
Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells. PloS one, 2013, Volume: 8, Issue:6 Topics: Antigens, CD; Antineoplastic Agents, Hormonal; Apoptosis; Base Sequence; Binding Sites; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Fatty Acid-Binding Proteins; Female; Gene Expression; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Kaplan-Meier Estimate; Molecular Sequence Data; Promoter Regions, Genetic; Proportional Hazards Models; Protein Binding; Resveratrol; Stilbenes; Tamoxifen; Transforming Growth Factor beta	2013
Piceatannol suppresses the metastatic potential of MCF10A human breast epithelial cells harboring mutated H-ras by inhibiting MMP-2 expression. International journal of molecular medicine, 2013, Volume: 32, Issue:4 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Epithelial Cells; Female; Gene Expression Regulation; Genes, ras; Humans; Matrix Metalloproteinase 2; Mutation; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; Wine	2013
Resveratrol sensitizes tamoxifen in antiestrogen-resistant breast cancer cells with epithelial-mesenchymal transition features. International journal of molecular sciences, 2013, Jul-26, Volume: 14, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Estrogen Antagonists; Female; Humans; MCF-7 Cells; Resveratrol; Signal Transduction; Smad Proteins; Stilbenes; Tamoxifen; Transforming Growth Factor beta	2013
3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Toxicology and applied pharmacology, 2013, Nov-01, Volume: 272, Issue:3 Topics: Anticarcinogenic Agents; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Humans; MCF-7 Cells; Neoplasm Invasiveness; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Resveratrol; Stilbenes; Wnt Signaling Pathway	2013
Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. Breast cancer research and treatment, 2013, Volume: 141, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Anticarcinogenic Agents; Antineoplastic Agents; Biological Availability; Biological Products; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Line, Tumor; Cholesterol; Chromatography, High Pressure Liquid; Curcumin; Drug Compounding; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Immunoconjugates; Liposomes; Neoplasm Proteins; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Receptor, ErbB-2; Resveratrol; Stilbenes; Trastuzumab	2013
Quercetin suppresses invasion and migration of H-Ras-transformed MCF10A human epithelial cells by inhibiting phosphatidylinositol 3-kinase. Food chemistry, 2014, Jan-01, Volume: 142 Topics: Breast Neoplasms; Cell Line, Transformed; Cell Movement; Down-Regulation; Enzyme Inhibitors; Epithelial Cells; Genes, ras; Humans; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins p21(ras); Quercetin; Resveratrol; Signal Transduction; Stilbenes; Wine	2014
Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene. Journal of nutritional science and vitaminology, 2013, Volume: 59, Issue:4 Topics: Alcohol Oxidoreductases; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Binding, Competitive; Breast Neoplasms; Chromatography, Affinity; Doxorubicin; Female; Humans; Hydroquinones; MCF-7 Cells; NADP; Phytotherapy; Plant Extracts; Protein Binding; Resveratrol; Stilbenes	2013
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines. Bioorganic & medicinal chemistry letters, 2013, Dec-01, Volume: 23, Issue:23 Topics: 3T3 Cells; Animals; Antineoplastic Agents, Phytogenic; Azetidines; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Mice; Resveratrol; Stilbenes	2013
Gestational exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces BRCA-1 promoter hypermethylation and reduces BRCA-1 expression in mammary tissue of rat offspring: preventive effects of resveratrol. Molecular carcinogenesis, 2015, Volume: 54, Issue:4 Topics: Animals; Anticarcinogenic Agents; BRCA1 Protein; Breast; Breast Neoplasms; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Developmental; Genes, BRCA1; Maternal Exposure; Polychlorinated Dibenzodioxins; Pregnancy; Promoter Regions, Genetic; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes; Teratogens	2015
Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Biochimica et biophysica acta, 2014, Volume: 1840, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tissue Distribution; Tumor Cells, Cultured	2014
Phytoestrogens induce apoptosis through a mitochondria/caspase pathway in human breast cancer cells. Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:4 Topics: Apoptosis; Breast Neoplasms; Caspase 3; Cell Proliferation; Estradiol; Fas Ligand Protein; Female; Genistein; Humans; MCF-7 Cells; Mitochondria; Phosphatidylinositol 3-Kinases; Phytoestrogens; Proto-Oncogene Proteins c-akt; Quercetin; Resveratrol; Signal Transduction; Stilbenes	2014
Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue. Nutrition and cancer, 2014, Volume: 66, Issue:2 Topics: Animals; Azacitidine; Breast; Breast Neoplasms; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Down-Regulation; Estrogens; Female; MicroRNAs; Rats; Rats, Inbred ACI; Resveratrol; Stilbenes	2014
Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway. Toxicology and applied pharmacology, 2014, Mar-15, Volume: 275, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Death; Cell Line, Transformed; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Epithelial Cells; Female; Flap Endonucleases; Humans; Mammary Glands, Human; Mice; Mice, Inbred BALB C; Proliferating Cell Nuclear Antigen; Resveratrol; RNA Interference; Signal Transduction; Smoke; Smoking; Stilbenes; Time Factors; Transfection; Up-Regulation; Xenograft Model Antitumor Assays	2014
In-situ detection of resveratrol inhibition effect on epidermal growth factor receptor of living MCF-7 cells by Atomic Force Microscopy. Biosensors & bioelectronics, 2014, Jun-15, Volume: 56 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Survival; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Immobilized Proteins; MCF-7 Cells; Microscopy, Atomic Force; Optical Imaging; Resveratrol; Stilbenes	2014
Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts. Toxicology in vitro : an international journal published in association with BIBRA, 2014, Volume: 28, Issue:7 Topics: Adipose Tissue; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Estradiol; Female; Fibroblasts; Gene Expression Regulation; Humans; Ki-67 Antigen; Letrozole; Melatonin; Nitriles; Resveratrol; Stilbenes; Testosterone; Trefoil Factor-1; Triazoles; Tumor Suppressor Proteins	2014
Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells. Journal of nutritional science and vitaminology, 2014, Volume: 60, Issue:2 Topics: Alcohol Oxidoreductases; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; MCF-7 Cells; Phytotherapy; Plant Extracts; Resveratrol; RNA, Messenger; Stilbenes	2014
Phytoestrogens induce differential effects on both normal and malignant human breast cells in vitro. Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:6 Topics: Apoptosis; Breast; Breast Neoplasms; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Genistein; Humans; In Situ Nick-End Labeling; MCF-7 Cells; Phytoestrogens; Quercetin; Resveratrol; Signal Transduction; Stilbenes	2014
Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells. Molecular nutrition & food research, 2014, Volume: 58, Issue:9 Topics: Animals; Biological Transport; Breast Neoplasms; Cell Line, Tumor; CHO Cells; Cricetulus; Female; Gene Knockdown Techniques; Glucuronides; Liver-Specific Organic Anion Transporter 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Resveratrol; Rifampin; Solute Carrier Organic Anion Transporter Family Member 1B3; Stilbenes	2014
Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway. PloS one, 2014, Volume: 9, Issue:7 Topics: Autophagy; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Neoplastic Stem Cells; Resveratrol; Signal Transduction; Stilbenes; Wnt Proteins	2014
Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2014, Volume: 23, Issue:6 Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Carcinogens; Celecoxib; Chemoprevention; Drug Synergism; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Methylnitrosourea; Pyrazoles; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfonamides	2014
Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells. Anticancer research, 2014, Volume: 34, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; Cytochrome P-450 CYP2C8; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Paclitaxel; Resveratrol; Stilbenes; Survivin; Tumor Stem Cell Assay	2014
The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells. Journal of cellular biochemistry, 2015, Volume: 116, Issue:3 Topics: Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Estrogen Receptor alpha; Female; Humans; Mechanistic Target of Rapamycin Complex 1; Models, Biological; Multiprotein Complexes; Proto-Oncogene Proteins c-akt; Resveratrol; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Up-Regulation	2015
mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Expert opinion on drug delivery, 2015, Volume: 12, Issue:3 Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Tolerance; Humans; Micelles; Polyesters; Polyethylene Glycols; Resveratrol; Stilbenes; Vitamin E	2015
Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitro. Oncotarget, 2014, Dec-30, Volume: 5, Issue:24 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression; Humans; Integrin alphaVbeta3; Resveratrol; Signal Transduction; Stilbenes	2014
Resveratrol suppresses the proliferation of breast cancer cells by inhibiting fatty acid synthase signaling pathway. Cancer epidemiology, 2014, Volume: 38, Issue:6 Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Receptor, ErbB-2; Resveratrol; Signal Transduction; Stilbenes	2014
Efficacy of antioxidants as a Complementary and Alternative Medicine (CAM) in combination with the chemotherapeutic agent doxorubicin. Integrative cancer therapies, 2015, Volume: 14, Issue:2 Topics: 3T3 Cells; Animals; Antibiotics, Antineoplastic; Antioxidants; Antrodia; Breast Neoplasms; Complementary Therapies; Curcumin; Doxorubicin; Drug Synergism; Female; Glucosides; Humans; MCF-7 Cells; Mice; Plant Extracts; Reactive Oxygen Species; Resveratrol; Stilbenes; Superoxide Dismutase	2015
A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation. Nature communications, 2015, Apr-29, Volume: 6 Topics: Adaptation, Physiological; Base Sequence; Breast Neoplasms; Carcinoma; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; In Situ Hybridization, Fluorescence; MCF-7 Cells; Molecular Sequence Data; Resveratrol; RNA, Untranslated; Stilbenes	2015
The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines. Scientific reports, 2015, Jul-09, Volume: 5 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Receptor, ErbB-2; Resveratrol; Stilbenes; Trastuzumab	2015
Resveratrol and curcumin synergistically induces apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21(Waf1/Cip1) mediated inhibition of Hh-Gli signaling. The international journal of biochemistry & cell biology, 2015, Volume: 66 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Breast Neoplasms; Cell Line; Cell Transformation, Neoplastic; Curcumin; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; Epithelial Cells; Female; Hedgehog Proteins; Humans; Immunoblotting; Mice, Inbred BALB C; Microscopy, Fluorescence; Nicotiana; Resveratrol; RNA Interference; Signal Transduction; Smoke; Stilbenes; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1	2015
Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ERα status. Oncotarget, 2015, Nov-03, Volume: 6, Issue:34 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Drug Interactions; Estrogen Receptor alpha; Female; Humans; Integrin alphaVbeta3; MCF-7 Cells; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes	2015
AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation. Cancer research, 2016, Mar-15, Volume: 76, Issue:6 Topics: Animals; beta-Transducin Repeat-Containing Proteins; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Heterocyclic Compounds, 3-Ring; Humans; Mice; Mice, Inbred BALB C; Phosphorylation; Proteolysis; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Twist-Related Protein 1	2016
Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death. Cell death & disease, 2016, Feb-18, Volume: 7 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; X-Linked Inhibitor of Apoptosis Protein	2016
BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1. Scientific reports, 2016, Feb-23, Volume: 6 Topics: Animals; BRCA1 Protein; Breast Neoplasms; Cell Proliferation; Female; Gene Expression; Genes, BRCA1; Humans; MCF-7 Cells; Metabolic Networks and Pathways; Mice; Mice, Inbred BALB C; Mice, Nude; Prognosis; Receptors, Androgen; Resveratrol; Sirtuin 1; Stilbenes	2016
Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo. Scientific reports, 2016, Mar-07, Volume: 6 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Carriers; Drug Resistance, Multiple; Female; Liposomes; Mice, Inbred BALB C; Paclitaxel; Resveratrol; Stilbenes; Treatment Outcome; Tubulin Modulators	2016
4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells. Toxicology and applied pharmacology, 2016, 06-15, Volume: 301 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Survival; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Resveratrol; RNA, Messenger; RNA, Small Interfering; Stilbenes	2016
Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells. Oncology reports, 2016, Volume: 35, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Aurora Kinase A; BRCA1 Protein; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cyclin B1; Cyclin D1; Female; G1 Phase Cell Cycle Checkpoints; Humans; MCF-7 Cells; Oligonucleotide Array Sequence Analysis; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; Stilbenes; Transcriptome	2016
A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells. PloS one, 2016, Volume: 11, Issue:5 Topics: Breast Neoplasms; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Estrogen Receptor alpha; Female; Humans; Promoter Regions, Genetic; Resveratrol; Stilbenes; Tamoxifen	2016
Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity. Carcinogenesis, 2016, Volume: 37, Issue:7 Topics: Breast Neoplasms; Cell Line, Tumor; Chromatin; CpG Islands; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Nuclear Proteins; Organic Cation Transporter 1; Promoter Regions, Genetic; Receptors, Notch; Resveratrol; Signal Transduction; Stilbenes; Trans-Activators; Transcription Factors; Transcriptional Activation	2016
Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade. PloS one, 2016, Volume: 11, Issue:6 Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents, Phytogenic; Breast; Breast Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice, Nude; Mice, SCID; Neoplasm Metastasis; Proto-Oncogene Proteins c-akt; Quercetin; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases; Vitis	2016
Tristetraprolin: a novel mediator of the anticancer properties of resveratrol. Genetics and molecular research : GMR, 2016, May-20, Volume: 15, Issue:2 Topics: Breast Neoplasms; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; MCF-7 Cells; Nitric Oxide Synthase Type II; Resveratrol; RNA-Binding Proteins; Stilbenes; Tristetraprolin; Vascular Endothelial Growth Factor A	2016
Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells. Oncotarget, 2016, Aug-09, Volume: 7, Issue:32 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Catechols; Cell Proliferation; Cells, Cultured; Drug Synergism; Female; Humans; MCF-7 Cells; Resveratrol; Schiff Bases; Stilbenes; Tamoxifen	2016
Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol. PloS one, 2016, Volume: 11, Issue:6 Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Line, Tumor; CpG Islands; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Resveratrol; Stilbenes	2016
Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells. Archives of toxicology, 2017, Volume: 91, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle Checkpoints; Cell Differentiation; Cell Respiration; Electron Transport Complex I; Female; Humans; Male; MCF-7 Cells; Mitochondria, Liver; Neoplastic Stem Cells; Rats, Wistar; Resveratrol; Sirtuin 1; Sirtuin 3; Stilbenes	2017
Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol. Journal of Asian natural products research, 2017, Volume: 19, Issue:9 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Models, Molecular; Molecular Structure; Resveratrol; Stilbenes; Structure-Activity Relationship	2017
Determination of trans-resveratrol and its metabolites in rat serum using liquid chromatography with high-resolution time of flight mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016, Dec-15, Volume: 1039 Topics: Animals; Antineoplastic Agents; Antioxidants; Breast Neoplasms; Chromatography, High Pressure Liquid; Deuterium Exchange Measurement; Female; Glucuronides; Limit of Detection; Rats; Resveratrol; Spectrometry, Mass, Electrospray Ionization; Stilbenes	2016
Resveratrol and its methoxy derivatives modulate the expression of estrogen metabolism enzymes in breast epithelial cells by AhR down-regulation. Molecular and cellular biochemistry, 2017, Volume: 425, Issue:1-2 Topics: Basic Helix-Loop-Helix Transcription Factors; Breast Neoplasms; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Down-Regulation; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes; Sulfotransferases	2017
Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Caspase 3; Cell Cycle Checkpoints; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; MCF-7 Cells; Niacinamide; Phenylurea Compounds; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Resveratrol; Sorafenib; Stilbenes; Treatment Outcome	2016
Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis. Experimental & molecular medicine, 2017, 02-24, Volume: 49, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Humans; Neoplasm Invasiveness; Phosphoproteins; Resveratrol; rhoA GTP-Binding Protein; Signal Transduction; Stilbenes; Transcription Factors; YAP-Signaling Proteins	2017
α-Tocopherol as functional excipient for resveratrol and coenzyme Q10-loaded SNEDDS for improved bioavailability and prophylaxis of breast cancer. Journal of drug targeting, 2017, Volume: 25, Issue:6 Topics: Administration, Oral; alpha-Tocopherol; Animals; Antioxidants; Area Under Curve; Biological Availability; Breast Neoplasms; Caco-2 Cells; Coumarins; Drug Delivery Systems; Emulsions; Excipients; Female; Humans; Nanoparticles; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Thiazoles; Ubiquinone	2017
ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells. International journal of oncology, 2008, Volume: 33, Issue:1 Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Enzyme Activation; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Resveratrol; RNA, Small Interfering; Stilbenes	2008
Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. International journal of oncology, 2008, Volume: 33, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Mice; Models, Biological; Resveratrol; Stilbenes; Superoxide Dismutase; Vitamin E	2008
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Molecular cell, 2008, Oct-10, Volume: 32, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Epigenesis, Genetic; Female; Genes, BRCA1; Germ-Line Mutation; Humans; Inhibitor of Apoptosis Proteins; Mammary Neoplasms, Experimental; Mice; Mice, Mutant Strains; Mice, Nude; Mice, Transgenic; Microtubule-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Repressor Proteins; Resveratrol; RNA Interference; Sirtuin 1; Sirtuins; Stilbenes; Survivin	2008
LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression. Experimental & molecular medicine, 2008, Oct-31, Volume: 40, Issue:5 Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Movement; Cell Survival; Chromatin Immunoprecipitation; Female; Gene Expression; Humans; Imines; Immunohistochemistry; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Phosphorylation; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Stilbenes; Xenograft Model Antitumor Assays	2008
Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:2 Topics: Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Cell Line; Cell Nucleus; Cell Transformation, Neoplastic; Chemoprevention; Cytochrome P-450 CYP1B1; DNA Adducts; Estradiol; Gene Expression Regulation, Enzymologic; Humans; Models, Biological; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Polychlorinated Dibenzodioxins; Protein Transport; Resveratrol; Stilbenes	2008
Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells. Experimental & molecular medicine, 2009, Mar-31, Volume: 41, Issue:3 Topics: Antineoplastic Agents; Aurora Kinase B; Aurora Kinases; Binding Sites; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colchicine; Cyclin B; Cyclin B1; G2 Phase; Humans; Microtubules; Models, Molecular; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Resveratrol; Stilbenes; Tubulin	2009
Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells. Planta medica, 2009, Volume: 75, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Inhibitory Concentration 50; Resveratrol; Stilbenes	2009
Structure-activity relationships of resveratrol and derivatives in breast cancer cells. Molecular nutrition & food research, 2009, Volume: 53, Issue:7 Topics: Binding Sites; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Resveratrol; Stilbenes; Structure-Activity Relationship	2009
Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism. Cancer letters, 2010, Mar-28, Volume: 289, Issue:2 Topics: Aged; Arylsulfatases; Arylsulfotransferase; Biomarkers, Tumor; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Fluorescent Antibody Technique, Indirect; Humans; Middle Aged; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steryl-Sulfatase; Stilbenes; Sulfotransferases	2010
Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. The Journal of nutritional biochemistry, 2010, Volume: 21, Issue:9 Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coumestrol; Estradiol; Estrogen Receptor alpha; Female; Genistein; Humans; Isoflavones; Phytoestrogens; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes	2010
Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:10 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Phosphorylation; Reactive Oxygen Species; Resveratrol; Stilbenes; Transplantation, Heterologous	2010
Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice. Journal of agricultural and food chemistry, 2010, Apr-14, Volume: 58, Issue:7 Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; Breast Neoplasms; Disease Models, Animal; Female; Humans; Mice; Mice, Knockout; Resveratrol; Stilbenes; Tissue Distribution	2010
Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. European journal of pharmacology, 2010, Jul-25, Volume: 638, Issue:1-3 Topics: Adenosine; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cholecalciferol; Cladribine; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Promoter Regions, Genetic; Receptors, Retinoic Acid; Resveratrol; Stilbenes; Transcriptional Activation; Tretinoin; Vidarabine	2010
Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-{kappa}B activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKK{beta} as a potential target. Carcinogenesis, 2010, Volume: 31, Issue:8 Topics: Anticarcinogenic Agents; Blotting, Western; Breast; Breast Neoplasms; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Cyclooxygenase 2; Cysteine; Epithelial Cells; Female; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; I-kappa B Kinase; NF-kappa B; Phenols; Phorbol Esters; Polyphenols; Resveratrol; Stilbenes; Wound Healing	2010
Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. The Journal of nutrition, 2010, Volume: 140, Issue:9 Topics: Anticarcinogenic Agents; Basic Helix-Loop-Helix Transcription Factors; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; DNA Damage; Epigenesis, Genetic; Estradiol; Estrogen Receptor alpha; Female; Gene Silencing; Humans; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes; Transcription, Genetic	2010
Dihydro-resveratrol--a potent dietary polyphenol. Bioorganic & medicinal chemistry letters, 2010, Oct-15, Volume: 20, Issue:20 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Female; Flavonoids; Humans; Neoplasms, Hormone-Dependent; Phenols; Polyphenols; Resveratrol; Stilbenes; Wine	2010
Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells. Cancer letters, 2010, Dec-28, Volume: 299, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Aryl Hydrocarbon Receptor Nuclear Translocator; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Kaempferols; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Stilbenes; Teratogens; Transcription, Genetic	2010
Role of phenolic compounds in nitric oxide synthase activity in colon and breast adenocarcinoma. Cancer biotherapy & radiopharmaceuticals, 2010, Volume: 25, Issue:5 Topics: Adenocarcinoma; Anticarcinogenic Agents; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chemoprevention; Colonic Neoplasms; Female; Humans; Nitric Oxide Synthase; Phenols; Resveratrol; Stilbenes; Tannins	2010
Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells. Free radical biology & medicine, 2011, Jan-01, Volume: 50, Issue:1 Topics: Acetylcysteine; Anticarcinogenic Agents; Breast Neoplasms; Carcinoma; Cell Line; Cell Transformation, Neoplastic; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Mammary Glands, Human; Models, Biological; Resveratrol; Stilbenes	2011
Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. Cancer letters, 2011, Feb-28, Volume: 301, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoblotting; Inhibitory Concentration 50; Membrane Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases	2011
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast cancer research and treatment, 2011, Volume: 130, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cell Proliferation; Cell Survival; Death-Associated Protein Kinases; Fatty Acid Synthases; Female; Gene Expression; Gene Knockdown Techniques; Humans; Lipogenesis; Membrane Proteins; Mice; Mice, Nude; Neoplastic Stem Cells; Proto-Oncogene Proteins; Resveratrol; RNA Interference; Stilbenes; Xenograft Model Antitumor Assays	2011
Role of Na+/H+ exchanger in resveratrol-induced growth inhibition of human breast cancer cells. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Breast Neoplasms; Cation Transport Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Fluorescent Antibody Technique; Humans; Microscopy, Confocal; Resveratrol; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Stilbenes	2012
Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3. International journal of cancer, 2011, Dec-01, Volume: 129, Issue:11 Topics: Anticarcinogenic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Estrogen Receptor alpha; Female; Flow Cytometry; Humans; Integrin alphaVbeta3; Mitogen-Activated Protein Kinases; Oligopeptides; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53	2011
Resveratrol as an adjunct therapy in cyclophosphamide-treated MCF-7 cells and breast tumor explants. Cancer science, 2011, Volume: 102, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Humans; Immunoprecipitation; Microscopy, Electron, Transmission; Middle Aged; Oxidative Stress; Resveratrol; Stilbenes; Tumor Cells, Cultured	2011
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system. PLoS computational biology, 2011, Feb-03, Volume: 7, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colonic Neoplasms; Computational Biology; Drug Therapy, Combination; Female; Humans; Models, Biological; Monte Carlo Method; Nanoparticles; Resveratrol; Stilbenes; Thyroxine	2011
Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1. Oncology reports, 2011, Volume: 25, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; E2F1 Transcription Factor; Female; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Stilbenes; Transfection; Up-Regulation	2011
Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Casein Kinase II; CCAAT-Binding Factor; Cell Line, Tumor; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase 1; Humans; p38 Mitogen-Activated Protein Kinases; Resveratrol; Sin3 Histone Deacetylase and Corepressor Complex; Stilbenes; Tumor Suppressor Protein p53	2011
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer letters, 2011, Nov-01, Volume: 310, Issue:1 Topics: Actin Depolymerizing Factors; Angiogenesis Inhibitors; Breast Neoplasms; Butadienes; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Enzyme Inhibitors; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Immunoblotting; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Repressor Proteins; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Snail Family Transcription Factors; Stilbenes; Transcription Factors; Vimentin; Zinc Finger E-box Binding Homeobox 2; Zinc Finger E-box-Binding Homeobox 1	2011
Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. The British journal of nutrition, 2012, Volume: 107, Issue:6 Topics: Adenocarcinoma; Adenosine; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cholecalciferol; Cyclin-Dependent Kinase Inhibitor p21; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Neoplasm Proteins; Promoter Regions, Genetic; PTEN Phosphohydrolase; Resveratrol; RNA, Messenger; Stilbenes; Tretinoin; Vitamins	2012
Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. Journal of agricultural and food chemistry, 2011, Nov-09, Volume: 59, Issue:21 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulation; Epidermal Growth Factor; Female; Gene Expression Regulation, Neoplastic; Humans; Mediator Complex; Plant Extracts; Resveratrol; Stilbenes	2011
Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein. ACS chemical biology, 2012, Feb-17, Volume: 7, Issue:2 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Survival; Drug Resistance, Neoplasm; Female; HEK293 Cells; Humans; Mitoxantrone; Neoplasm Proteins; Resveratrol; Stilbenes	2012
BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells. The Journal of nutritional biochemistry, 2012, Volume: 23, Issue:10 Topics: BRCA1 Protein; Breast Neoplasms; Carcinogens; DNA Methylation; Estradiol; Estrogen Receptor alpha; Exons; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Ligands; MCF-7 Cells; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Response Elements; Resveratrol; Sequence Analysis, DNA; Stilbenes	2012
Skin toxicity from external beam radiation therapy in breast cancer patients: protective effects of Resveratrol, Lycopene, Vitamin C and anthocianin (Ixor®). Radiation oncology (London, England), 2012, Jan-30, Volume: 7 Topics: Adult; Aged; Aged, 80 and over; Anthocyanins; Antioxidants; Ascorbic Acid; Breast Neoplasms; Carotenoids; Female; Humans; Lycopene; Middle Aged; Prognosis; Radiation-Protective Agents; Radiodermatitis; Radiotherapy, Conformal; Resveratrol; Stilbenes; Vitamins	2012
Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest. Journal of cellular biochemistry, 2012, Volume: 113, Issue:8 Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Female; Humans; Immunoprecipitation; Melphalan; Resveratrol; Stilbenes	2012
Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2013, Volume: 22, Issue:1 Topics: Angiogenesis Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Repair; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; Resveratrol; Stilbenes	2013
Halloysite clay nanotubes for resveratrol delivery to cancer cells. Macromolecular bioscience, 2012, Volume: 12, Issue:9 Topics: Aluminum Silicates; Antioxidants; Breast Neoplasms; Clay; Humans; Kinetics; MCF-7 Cells; Microscopy, Electron, Transmission; Nanotubes; Resveratrol; Stilbenes	2012
Grape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer. Nutrition and cancer, 2012, Volume: 64, Issue:7 Topics: Adenylate Kinase; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Female; Gefitinib; Gene Expression Regulation; Humans; Mice; Mice, SCID; Polyphenols; Proto-Oncogene Proteins c-akt; Quercetin; Quinazolines; Resveratrol; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Vitis; Xenograft Model Antitumor Assays	2012
Transient transfection of a wild-type p53 gene triggers resveratrol-induced apoptosis in cancer cells. PloS one, 2012, Volume: 7, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; MCF-7 Cells; Resveratrol; Stilbenes; Transcriptional Activation; Transfection; Tumor Suppressor Protein p53	2012
Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer. Oncogene, 2013, Oct-17, Volume: 32, Issue:42 Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Lipogenesis; Mice; Mice, Nude; Resveratrol; Stem Cells; Sterol Regulatory Element Binding Protein 1; Stilbenes; Xenograft Model Antitumor Assays	2013
Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation. Archives of toxicology, 2013, Volume: 87, Issue:5 Topics: Antineoplastic Agents; Breast Neoplasms; Cytochrome P-450 CYP1A1; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Humans; Indoles; Ligands; MCF-7 Cells; Protein-Tyrosine Kinases; Pyrroles; Receptors, Aryl Hydrocarbon; Resveratrol; RNA, Messenger; Stilbenes; Sunitinib; Transcriptional Activation	2013
Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice. BMC complementary and alternative medicine, 2013, Jan-08, Volume: 13 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Immunologic Deficiency Syndromes; Mice; Mice, Hairless; Mice, Nude; Neoplasm Metastasis; p21-Activated Kinases; Plant Extracts; Polyphenols; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Resveratrol; Stilbenes; Vitis	2013
Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer research, 2002, Sep-01, Volume: 62, Issue:17 Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Carcinogens; Cell Division; Cyclooxygenase 2; Female; Humans; Immunohistochemistry; Isoenzymes; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Proteins; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochemical pharmacology, 2002, Nov-01, Volume: 64, Issue:9 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Survival; Enzyme Inhibitors; Humans; Resveratrol; Ribonucleotide Reductases; Stilbenes; Tumor Cells, Cultured	2002
Flavonoid effects relevant to cancer. The Journal of nutrition, 2002, Volume: 132, Issue:11 Suppl Topics: Breast Neoplasms; Cell Division; Cell Survival; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Flavonoids; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genistein; Humans; Isoflavones; Phosphorylation; Phytoestrogens; Plant Preparations; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Resveratrol; Stilbenes; Tumor Cells, Cultured	2002
Hormonal and genotoxic activity of resveratrol. Toxicology letters, 2002, Dec-15, Volume: 136, Issue:2 Topics: Animals; Breast Neoplasms; Cell Cycle; Cell Division; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Fluorescein-5-isothiocyanate; Humans; Kinetochores; Lymphoma; Metaphase; Mice; Micronucleus Tests; Molecular Structure; Protein Binding; Receptors, Estrogen; Resveratrol; Stilbenes; Time Factors; Tubulin; Tumor Cells, Cultured	2002
Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha. International journal of cancer, 2003, May-01, Volume: 104, Issue:5 Topics: Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Receptors, Estrogen; Resveratrol; RNA, Messenger; Stilbenes; Transcriptional Activation; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured	2003
Estrogenic activity in white and red wine extracts. Journal of agricultural and food chemistry, 2003, Mar-26, Volume: 51, Issue:7 Topics: Animals; beta-Galactosidase; Breast Neoplasms; CHO Cells; Cricetinae; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Gene Expression; Genes, Reporter; Humans; Plant Extracts; Receptors, Estrogen; Response Elements; Resveratrol; Saccharomyces cerevisiae; Stilbenes; Tamoxifen; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Vitis; Wine	2003
Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. The Journal of steroid biochemistry and molecular biology, 2003, Volume: 84, Issue:2-3 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Calcitriol; Cell Cycle; Dose-Response Relationship, Drug; Estrogens, Non-Steroidal; Flow Cytometry; Genes, Reporter; Genistein; Humans; Isoflavones; Phytoestrogens; Plant Preparations; Promoter Regions, Genetic; Protein Binding; Protein Structure, Tertiary; Receptors, Calcitriol; Resveratrol; Stilbenes; Tamoxifen; Time Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Up-Regulation	2003
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis, 2003, Volume: 24, Issue:5 Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Antineoplastic Agents, Phytogenic; Arachidonic Acids; Breast Neoplasms; Cell Division; Cyclic AMP; Cyclic GMP; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; Receptors, Estrogen; Resveratrol; Rolipram; Stilbenes; Tamoxifen; Tumor Cells, Cultured	2003
Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines. British journal of cancer, 2003, Jul-07, Volume: 89, Issue:1 Topics: Anticarcinogenic Agents; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; DNA Primers; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Cells, Cultured	2003
Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:15 Topics: Acyltransferases; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Division; Cell Line, Tumor; Ceramides; Enzyme Inhibitors; Female; Humans; Models, Biological; Neoplasm Metastasis; Resveratrol; Serine C-Palmitoyltransferase; Signal Transduction; Sphingomyelins; Stilbenes	2003
Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncology reports, 2004, Volume: 11, Issue:2 Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; DNA Primers; Female; Humans; Neoplasm Proteins; Phytotherapy; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Vitis; Wine	2004
Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer research, 2004, Jan-01, Volume: 64, Issue:1 Topics: Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Brain Neoplasms; Breast Neoplasms; Caspase Inhibitors; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cysteine Proteinase Inhibitors; DNA Primers; Female; Humans; Male; Melanoma; Membrane Glycoproteins; Pancreatic Neoplasms; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2004
Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. International journal of cancer, 2004, Mar-20, Volume: 109, Issue:2 Topics: Antioxidants; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fulvestrant; Glycogen Synthase Kinase 3; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Polymerase Chain Reaction; Precipitin Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Resveratrol; Signal Transduction; Stilbenes; Tumor Cells, Cultured	2004
Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2. The Journal of steroid biochemistry and molecular biology, 2004, Volume: 88, Issue:3 Topics: Breast Neoplasms; Cell Line, Tumor; Estrogens; Humans; Resveratrol; RNA, Messenger; Stilbenes; Transforming Growth Factor alpha	2004
Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines. Clinica chimica acta; international journal of clinical chemistry, 2004, Volume: 344, Issue:1-2 Topics: Antineoplastic Agents, Phytogenic; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Receptors, Estrogen; Resveratrol; Stilbenes; Transcription, Genetic; Tumor Suppressor Proteins	2004
Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol. Journal of alternative and complementary medicine (New York, N.Y.), 2004, Volume: 10, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Astrocytoma; Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Resveratrol; Signal Transduction; Stilbenes; Time Factors; Transcriptional Activation; Tumor Suppressor Protein p53	2004
Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells. British journal of cancer, 2004, Jul-05, Volume: 91, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Estradiol; Female; Humans; Phosphorylation; Protein Processing, Post-Translational; Resveratrol; Ribonucleotide Reductases; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2004
Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage. The Biochemical journal, 2005, Jan-01, Volume: 385, Issue:Pt 1 Topics: Breast Neoplasms; Cell Line, Tumor; DNA Damage; Enzyme Induction; Estrogen Receptor beta; Estrogens; Genistein; Humans; Ligands; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Phytoestrogens; Response Elements; Resveratrol; Stilbenes; Transcription, Genetic	2005
Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites. Molecular and cellular endocrinology, 2005, Jan-31, Volume: 230, Issue:1-2 Topics: Binding Sites; Breast Neoplasms; Consensus Sequence; CpG Islands; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Exons; Humans; Mutation; Promoter Regions, Genetic; Receptors, Calcitriol; Resveratrol; Sp1 Transcription Factor; Stilbenes; Transcriptional Activation; Tumor Cells, Cultured; Vitamin D	2005
Resveratrol and breast cancer risk. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2005, Volume: 14, Issue:2 Topics: Adult; Anticarcinogenic Agents; Breast Neoplasms; Case-Control Studies; Diet; Female; Fruit; Humans; Incidence; Middle Aged; Odds Ratio; Resveratrol; Risk Factors; Stilbenes; Switzerland; Wine	2005
Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia (New York, N.Y.), 2005, Volume: 7, Issue:2 Topics: Actins; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Membrane; Cell Movement; Cytoskeleton; Epidermal Growth Factor; ErbB Receptors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Humans; Protein-Tyrosine Kinases; Pseudopodia; Resveratrol; Stilbenes; Tumor Cells, Cultured	2005
Resveratrol regulates insulin-like growth factor-II in breast cancer cells. Endocrinology, 2005, Volume: 146, Issue:10 Topics: Angiogenesis Inhibitors; Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Female; Humans; Insulin-Like Growth Factor II; Resveratrol; RNA, Messenger; Stilbenes	2005
Polyphenol interaction with the T47D human breast cancer cell line. The Journal of dairy research, 2005, Volume: 72 Spec No Topics: Breast Neoplasms; Catechin; Cell Cycle; Cell Division; Cell Line, Tumor; Flavonoids; Humans; Kinetics; Nitric Oxide; Nitric Oxide Synthase; Phenols; Polyphenols; Quercetin; Resveratrol; S Phase; Stilbenes; Wine	2005
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer letters, 2006, Jan-08, Volume: 231, Issue:1 Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Resveratrol; Stilbenes; Transplantation, Heterologous; Vascular Endothelial Growth Factor A	2006
Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells. Growth factors (Chur, Switzerland), 2006, Volume: 24, Issue:1 Topics: Anticarcinogenic Agents; Breast Neoplasms; Cathepsin D; Cell Line, Tumor; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor II; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Resveratrol; RNA, Messenger; Stilbenes	2006
Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. International journal of oncology, 2006, Volume: 28, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Female; Flow Cytometry; Humans; Microscopy, Confocal; Resveratrol; Stilbenes; Telomerase; Time Factors	2006
Bifunctional effect of resveratrol on the expression of ErbB2 in human breast cancer cell. Cancer letters, 2006, Oct-28, Volume: 242, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Mutation; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Receptor, ErbB-2; Receptors, Growth Factor; Resveratrol; Stilbenes; Transcription Factor AP-2	2006
The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicological sciences : an official journal of the Society of Toxicology, 2006, Volume: 92, Issue:1 Topics: Aromatase; Aromatase Inhibitors; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Primers; Humans; Kinetics; Promoter Regions, Genetic; Resveratrol; RNA, Messenger; Stilbenes; Testosterone; Wine	2006
Strategies for comparing gene expression profiles from different microarray platforms: application to a case-control experiment. Analytical biochemistry, 2006, Jun-01, Volume: 353, Issue:1 Topics: Breast Neoplasms; Case-Control Studies; Computational Biology; DNA, Complementary; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Meta-Analysis as Topic; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Reproducibility of Results; Resveratrol; Sensitivity and Specificity; Stilbenes	2006
Analysis of the resveratrol-binding protein using phage-displayed random peptide library. Acta biochimica et biophysica Sinica, 2006, Volume: 38, Issue:5 Topics: Breast; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Humans; Mammary Glands, Human; Peptide Library; Peptides; Resveratrol; Stilbenes	2006
Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:10 Topics: Apoptosis; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Integrin alphaVbeta3; Integrin beta3; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53	2006
Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Molecular cancer therapeutics, 2006, Volume: 5, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Nucleus; Cyclooxygenase 2; E1A-Associated p300 Protein; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Resveratrol; Serine; Signal Transduction; Stilbenes; Transcription Factor AP-1; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2006
Resveratrol impairs the formation of MDA-MB-231 multicellular tumor spheroids concomitant with ceramide accumulation. Cancer letters, 2007, May-08, Volume: 249, Issue:2 Topics: Breast Neoplasms; Cell Aggregation; Ceramides; Female; Humans; Resveratrol; Spheroids, Cellular; Stilbenes; Tumor Cells, Cultured	2007
[Resveratrol inhibits expression of EMMPRIN from macrophages]. Yao xue xue bao = Acta pharmaceutica Sinica, 2006, Volume: 41, Issue:7 Topics: Anilides; Antineoplastic Agents, Phytogenic; Basigin; Blotting, Western; Breast Neoplasms; Cell Differentiation; Cell Line; Cell Line, Tumor; Coculture Techniques; Dose-Response Relationship, Drug; Female; Humans; Luciferases; Macrophages; Matrix Metalloproteinase 9; Monocytes; Pioglitazone; PPAR gamma; Recombinant Fusion Proteins; Resveratrol; Stilbenes; Thiazolidinediones; U937 Cells	2006
The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models. Molecular pharmacology, 2007, Volume: 71, Issue:1 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cell Line; Cell Line, Tumor; Dogs; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Liver; Methotrexate; Mitoxantrone; Neoplasm Proteins; Rabbits; Resveratrol; Stilbenes; Topotecan	2007
[Studies on active substance of anticancer effect in Polygonum cuspidatum]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2006, Volume: 29, Issue:7 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Epithelial Cells; Fallopia japonica; Female; Humans; Liver Neoplasms; Plants, Medicinal; Rats; Resveratrol; Rhizome; Stilbenes	2006
Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9. Applied biochemistry and biotechnology, 2006, Volume: 135, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 9; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Oncogene Protein v-akt; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes	2006
Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells. Neoplasia (New York, N.Y.), 2007, Volume: 9, Issue:2 Topics: Actins; Adenocarcinoma; Breast Neoplasms; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Movement; Cytoskeleton; Dose-Response Relationship, Drug; Epidermal Growth Factor; Estradiol; Estrogens; Female; Genes, Dominant; Humans; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Pseudopodia; rac GTP-Binding Proteins; Recombinant Fusion Proteins; Resveratrol; Stilbenes; Transfection	2007
Differential expression of genes induced by resveratrol in human breast cancer cell lines. Nutrition and cancer, 2006, Volume: 56, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Humans; Receptors, Estrogen; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Transcription, Genetic	2006
Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway. British journal of cancer, 2007, May-21, Volume: 96, Issue:10 Topics: Breast Neoplasms; Glycogen Synthase Kinase 3; Humans; Male; Models, Biological; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Protein Binding; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Receptors, Estrogen; Resveratrol; Signal Transduction; Stilbenes; Tumor Cells, Cultured	2007
Effect of formaldehyde and resveratrol on the viability of Vero, HepG2 and MCF-7 cells. Cell biology international, 2007, Volume: 31, Issue:10 Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Disinfectants; Formaldehyde; Liver Neoplasms; Receptors, Estrogen; Resveratrol; Stilbenes; Vero Cells	2007
Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells. Pharmacology, 2007, Volume: 80, Issue:2-3 Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Poly Adenosine Diphosphate Ribose; Protein Biosynthesis; Resveratrol; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53	2007
Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2007, Volume: 16, Issue:4 Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Enzyme Activation; Female; Humans; MAP Kinase Signaling System; Neoplasm Proteins; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Biosynthesis; Protein Kinase Inhibitors; Resveratrol; Ribosomal Protein S6; Serum; Stilbenes	2007
Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. The Journal of nutritional biochemistry, 2008, Volume: 19, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Enzyme Activation; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neuregulin-1; Phosphorylation; Receptor, ErbB-2; Resveratrol; Stilbenes; Tissue Inhibitor of Metalloproteinases	2008
Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Molecular pharmacology, 2007, Volume: 72, Issue:6 Topics: Animals; Apoptosis; Breast Neoplasms; Calcium; Calpain; Cell Line, Tumor; Female; Humans; Mice; Mice, Nude; Mitochondria; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays	2007
Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2008, Volume: 46, Issue:4 Topics: Antineoplastic Agents; Antioxidants; Breast Neoplasms; Cell Count; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA; Female; Flow Cytometry; Humans; Purines; Resveratrol; Roscovitine; Stilbenes	2008
Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer letters, 2008, Mar-18, Volume: 261, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Arylsulfotransferase; Breast Neoplasms; Cell Proliferation; Chromatography, High Pressure Liquid; Chromatography, Liquid; DNA Primers; Female; Gene Expression Regulation, Enzymologic; Growth Inhibitors; Humans; Mass Spectrometry; Neoplasms, Hormone-Dependent; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Cells, Cultured	2008
Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway. Archives of medical research, 2008, Volume: 39, Issue:2 Topics: Antioxidants; Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Female; Humans; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Processing, Post-Translational; Resveratrol; Stilbenes	2008
Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B. Journal of proteome research, 2008, Volume: 7, Issue:4 Topics: Apoptosis; Aurovertins; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Membrane Proteins; Mitochondrial Proton-Translocating ATPases; Models, Molecular; Resveratrol; Stilbenes; Up-Regulation	2008
Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol. Cancer chemotherapy and pharmacology, 2008, Volume: 63, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Biopolymers; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Estrogens; Female; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Resveratrol; STAT3 Transcription Factor; Stilbenes; Tubulin	2008
Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds. Oncology reports, 2008, Volume: 19, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Clone Cells; Drug Resistance, Neoplasm; Female; Genes, erbB-2; Genes, p53; Humans; Resveratrol; Stilbenes	2008
Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells. Growth factors (Chur, Switzerland), 2007, Volume: 25, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Caspase 7; Cell Line, Tumor; Cell Survival; Enzyme Activation; Humans; Inhibitor of Apoptosis Proteins; Insulin-Like Growth Factor II; Membrane Potential, Mitochondrial; Microtubule-Associated Proteins; Mitochondria; Neoplasm Proteins; Protein Precursors; Protein Processing, Post-Translational; Resveratrol; Signal Transduction; Stilbenes; Survivin	2007
Resveratrol inhibits migration and invasion of human breast-cancer cells. Molecular nutrition & food research, 2008, Volume: 52, Issue:6 Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Enzyme Activation; Gene Expression; Humans; Insulin-Like Growth Factor I; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes	2008
Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell death and differentiation, 2008, Volume: 15, Issue:8 Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 7; Beclin-1; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Humans; Membrane Proteins; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Ubiquitin-Activating Enzymes; Vesicular Transport Proteins	2008
Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol. Free radical biology & medicine, 2008, Jul-15, Volume: 45, Issue:2 Topics: Antioxidants; Breast Neoplasms; Cell Line, Tumor; Chromatography, Liquid; DNA Adducts; Estrogens; Female; Humans; NAD(P)H Dehydrogenase (Quinone); Resveratrol; Stilbenes; Tandem Mass Spectrometry	2008
Precursor IGF-II (proIGF-II) and mature IGF-II (mIGF-II) induce Bcl-2 And Bcl-X L expression through different signaling pathways in breast cancer cells. Growth factors (Chur, Switzerland), 2008, Volume: 26, Issue:2 Topics: Antineoplastic Agents, Phytogenic; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cytochromes c; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor II; Intracellular Signaling Peptides and Proteins; Mitochondrial Membranes; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Resveratrol; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Stilbenes	2008
Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth. Nutrition and cancer, 2008, Volume: 60, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Caspases; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Male; Organoselenium Compounds; Prostatic Neoplasms; Resveratrol; Stilbenes; Tocopherols; Vitamin E	2008
A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol. Toxicology, 2008, Jun-27, Volume: 248, Issue:2-3 Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Estrogens; Feedback, Physiological; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Resveratrol; RNA, Messenger; Stilbenes	2008
Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proceedings of the National Academy of Sciences of the United States of America, 1997, Dec-09, Volume: 94, Issue:25 Topics: Breast Neoplasms; Cardiovascular Diseases; Cell Division; Estradiol; Estrogens, Non-Steroidal; Female; Genes, Reporter; Humans; Isoflavones; Organ Specificity; Phytoestrogens; Plant Preparations; Receptors, Estrogen; Resveratrol; Rosales; Stilbenes; Transcriptional Activation; Tumor Cells, Cultured; Wine	1997
Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. International journal of oncology, 1998, Volume: 12, Issue:4 Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Epithelial Cells; Female; Humans; Resveratrol; Stilbenes; Tumor Cells, Cultured	1998
Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? European journal of endocrinology, 1998, Volume: 138, Issue:6 Topics: Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Estrogens, Non-Steroidal; Female; France; Humans; Isoflavones; Mammary Neoplasms, Experimental; Mice; Phytoestrogens; Plant Preparations; Plants; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Wine	1998
Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 1998, Aug-01, Volume: 92, Issue:3 Topics: Antibodies, Monoclonal; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Fragmentation; DNA, Neoplasm; Fas Ligand Protein; fas Receptor; Female; HL-60 Cells; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Lymphocytes; Membrane Glycoproteins; Membrane Lipids; Neoplasm Proteins; Phosphatidylserines; Resveratrol; Rosales; Signal Transduction; Stilbenes; Tumor Cells, Cultured	1998
Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. Journal of cellular physiology, 1999, Volume: 179, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Division; Culture Media; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Gene Expression Regulation, Neoplastic; Humans; Receptor, IGF Type 1; Resveratrol; RNA, Messenger; Rosales; Stilbenes; Transcriptional Activation; Transforming Growth Factor alpha; Tumor Cells, Cultured	1999
Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. International journal of oncology, 1999, Volume: 15, Issue:2 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Chemoprevention; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; Resveratrol; Stilbenes; Transfection	1999
"Soybean" in a Haystack? pinpointing an anti-cancer effect. Journal of the National Cancer Institute, 1999, Oct-06, Volume: 91, Issue:19 Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Colorectal Neoplasms; Garlic; Glycine max; Humans; Neoplasms; Phytotherapy; Plants, Medicinal; Resveratrol; Selenium; Stilbenes; Tea	1999
Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants. International journal of oncology, 1999, Volume: 15, Issue:5 Topics: Alkaline Phosphatase; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Renal Cell; Cell Differentiation; Cell Line; Culture Media, Conditioned; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Kidney Neoplasms; Lung; Male; Osteoblasts; Pancreatic Neoplasms; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Resveratrol; Stilbenes; Tamoxifen; Tumor Cells, Cultured	1999
Potent inhibitory action of red wine polyphenols on human breast cancer cells. Journal of cellular biochemistry, 2000, Jun-06, Volume: 78, Issue:3 Topics: Antioxidants; Breast Neoplasms; Catechin; Cell Division; Cell Survival; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Estradiol; Female; Flavonoids; Flow Cytometry; Humans; Hydrogen Peroxide; Phenols; Polymers; Progesterone; Reactive Oxygen Species; Receptors, Steroid; Resveratrol; Stilbenes; Time Factors; Tumor Cells, Cultured; Wine	2000
Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. Journal of cancer research and clinical oncology, 2001, Volume: 127, Issue:4 Topics: Anticarcinogenic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; bcl-X Protein; Breast Neoplasms; Cell Division; Female; Humans; Linoleic Acid; Membrane Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Resveratrol; Stilbenes; Tumor Cells, Cultured	2001
Do wine polyphenols modulate p53 gene expression in human cancer cell lines? Clinical biochemistry, 2001, Volume: 34, Issue:5 Topics: Antioxidants; Breast Neoplasms; Caffeic Acids; Catechin; Colonic Neoplasms; Flavonoids; Fluoroimmunoassay; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Models, Structural; Phenols; Polymers; Quercetin; Resveratrol; Stilbenes; Time Factors; Tumor Cells, Cultured; Wine	2001
Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells. Biochemical pharmacology, 2001, Oct-15, Volume: 62, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cytochrome P-450 CYP1A1; Enzyme Stability; Gene Silencing; Humans; Receptors, Aryl Hydrocarbon; Resveratrol; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Stilbenes; Tumor Cells, Cultured	2001
Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells. Antioxidants & redox signaling, 2001, Volume: 3, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Estradiol; Humans; Insulin-Like Growth Factor I; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Transforming Growth Factor beta3; Tumor Cells, Cultured	2001
Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta medica, 2002, Volume: 68, Issue:5 Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Breast Neoplasms; Cell Division; Cell Survival; Drug Interactions; Estrogens, Non-Steroidal; Flavonoids; Humans; Isoflavones; Kaempferols; Phytoestrogens; Plant Extracts; Plant Preparations; Plants; Quercetin; Resveratrol; Stilbenes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vitamin E	2002